Query 013357
Match_columns 444
No_of_seqs 231 out of 2051
Neff 10.2
Searched_HMMs 46136
Date Fri Mar 29 03:02:11 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/013357.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/013357hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0534 NorM Na+-driven multid 100.0 2.7E-50 5.9E-55 393.4 49.2 383 44-429 12-398 (455)
2 PRK10189 MATE family multidrug 100.0 7.9E-46 1.7E-50 365.4 50.3 383 42-427 22-414 (478)
3 PRK00187 multidrug efflux prot 100.0 8.4E-46 1.8E-50 365.1 50.1 386 43-431 4-400 (464)
4 PRK10367 DNA-damage-inducible 100.0 1.5E-45 3.3E-50 360.1 48.7 379 45-427 5-390 (441)
5 PRK09575 vmrA multidrug efflux 100.0 4.3E-45 9.3E-50 359.5 47.8 389 44-435 7-399 (453)
6 PRK01766 multidrug efflux prot 100.0 5.9E-44 1.3E-48 353.0 49.8 386 42-430 5-397 (456)
7 TIGR00797 matE putative efflux 100.0 4.1E-37 8.8E-42 293.4 43.8 338 57-397 1-341 (342)
8 KOG1347 Uncharacterized membra 100.0 5.4E-33 1.2E-37 269.5 36.9 387 45-440 24-410 (473)
9 TIGR01695 mviN integral membra 100.0 1.3E-31 2.9E-36 268.7 46.2 380 51-439 2-395 (502)
10 TIGR02900 spore_V_B stage V sp 100.0 2.5E-31 5.4E-36 265.9 42.8 378 52-437 2-397 (488)
11 PRK15099 O-antigen translocase 100.0 1.8E-28 3.8E-33 239.8 42.6 369 51-435 3-375 (416)
12 PF03023 MVIN: MviN-like prote 100.0 1.1E-24 2.4E-29 213.4 44.9 355 79-441 5-372 (451)
13 COG0728 MviN Uncharacterized m 99.9 3.3E-23 7.1E-28 199.8 44.0 387 47-438 5-403 (518)
14 PRK10459 colanic acid exporter 99.9 8E-22 1.7E-26 197.2 41.9 360 49-434 5-367 (492)
15 COG2244 RfbX Membrane protein 99.9 7.9E-21 1.7E-25 189.6 36.4 377 46-441 3-381 (480)
16 PRK00187 multidrug efflux prot 99.9 4.7E-22 1E-26 196.4 26.0 209 42-251 229-444 (464)
17 COG0534 NorM Na+-driven multid 99.9 3.3E-21 7.1E-26 188.8 26.7 213 39-253 231-445 (455)
18 PRK10189 MATE family multidrug 99.9 6.1E-21 1.3E-25 188.7 27.9 212 43-255 253-466 (478)
19 PRK01766 multidrug efflux prot 99.9 5.2E-21 1.1E-25 189.4 25.4 208 43-251 233-442 (456)
20 PRK09575 vmrA multidrug efflux 99.9 3.2E-20 6.9E-25 183.1 26.5 207 42-251 227-436 (453)
21 TIGR01695 mviN integral membra 99.8 2.7E-18 5.9E-23 172.4 31.2 206 44-251 218-428 (502)
22 PRK10367 DNA-damage-inducible 99.8 6.8E-17 1.5E-21 158.4 26.7 199 46-251 229-431 (441)
23 PF03023 MVIN: MviN-like prote 99.8 8.5E-16 1.8E-20 150.9 30.5 207 43-251 192-403 (451)
24 PF01943 Polysacc_synt: Polysa 99.8 5.9E-15 1.3E-19 135.8 33.2 270 52-338 2-272 (273)
25 TIGR02900 spore_V_B stage V sp 99.8 1.9E-16 4.2E-21 158.5 24.5 204 43-251 219-434 (488)
26 PF01554 MatE: MatE; InterPro 99.7 2.1E-18 4.5E-23 145.9 6.2 160 57-217 1-162 (162)
27 COG0728 MviN Uncharacterized m 99.7 2.5E-14 5.4E-19 138.6 34.3 208 43-252 226-438 (518)
28 PRK10459 colanic acid exporter 99.7 2.3E-14 5.1E-19 143.5 34.0 202 44-251 202-405 (492)
29 PRK15099 O-antigen translocase 99.7 9.8E-15 2.1E-19 142.9 25.8 203 42-251 208-412 (416)
30 PF01554 MatE: MatE; InterPro 99.7 9.4E-17 2E-21 135.7 5.4 156 278-435 1-157 (162)
31 PF13440 Polysacc_synt_3: Poly 99.6 6.4E-12 1.4E-16 114.1 31.6 245 68-337 3-250 (251)
32 COG2244 RfbX Membrane protein 99.6 4.7E-13 1E-17 133.7 25.8 187 44-236 208-396 (480)
33 TIGR00797 matE putative efflux 99.5 1.2E-12 2.6E-17 124.8 19.6 158 278-437 1-158 (342)
34 KOG1347 Uncharacterized membra 99.0 1.3E-09 2.8E-14 106.7 9.2 205 45-250 243-451 (473)
35 PF07260 ANKH: Progressive ank 99.0 2.3E-06 5E-11 76.6 28.6 316 45-370 7-343 (345)
36 PF04506 Rft-1: Rft protein; 98.8 7.1E-06 1.5E-10 81.8 27.9 365 53-418 5-412 (549)
37 PF14667 Polysacc_synt_C: Poly 98.6 7.3E-06 1.6E-10 67.5 17.8 79 171-251 2-80 (146)
38 PF04506 Rft-1: Rft protein; 98.4 4.3E-05 9.3E-10 76.3 21.4 203 48-251 252-470 (549)
39 KOG2864 Nuclear division RFT1 98.4 0.00082 1.8E-08 63.4 28.0 363 47-418 6-392 (530)
40 KOG2864 Nuclear division RFT1 97.9 0.0067 1.4E-07 57.5 22.2 200 50-251 240-449 (530)
41 PF01943 Polysacc_synt: Polysa 97.4 0.00085 1.9E-08 61.3 9.5 72 44-116 200-272 (273)
42 PF07260 ANKH: Progressive ank 97.3 0.029 6.3E-07 51.0 16.6 144 266-415 7-153 (345)
43 COG4267 Predicted membrane pro 97.1 0.26 5.7E-06 45.9 25.7 266 97-384 72-359 (467)
44 PF13440 Polysacc_synt_3: Poly 96.4 0.3 6.4E-06 43.8 16.9 128 291-434 6-134 (251)
45 COG4267 Predicted membrane pro 86.8 24 0.00053 33.4 13.3 117 125-248 322-439 (467)
46 PF14667 Polysacc_synt_C: Poly 76.6 3.5 7.6E-05 33.3 3.8 49 394-442 2-50 (146)
47 PF04505 Dispanin: Interferon- 69.3 33 0.00071 24.8 6.9 42 323-364 32-73 (82)
48 KOG0569 Permease of the major 47.0 3.1E+02 0.0068 27.5 18.7 34 194-229 400-433 (485)
49 PRK03612 spermidine synthase; 45.5 3.4E+02 0.0075 27.5 23.1 50 198-249 149-198 (521)
50 PF02487 CLN3: CLN3 protein; 41.9 53 0.0011 31.9 5.3 29 41-69 235-263 (402)
51 TIGR03753 blh_monoox beta-caro 38.2 3.1E+02 0.0067 24.9 13.6 23 422-444 165-187 (259)
52 PF01914 MarC: MarC family int 38.2 2.7E+02 0.0058 24.2 9.5 60 332-395 21-80 (203)
53 PRK10739 putative antibiotic t 37.9 2.7E+02 0.0058 24.1 8.9 61 332-396 21-81 (197)
54 PF03904 DUF334: Domain of unk 37.7 1.3E+02 0.0029 26.3 6.4 61 122-182 143-212 (230)
55 PF03609 EII-Sor: PTS system s 34.0 3.4E+02 0.0074 24.2 14.7 68 313-380 102-170 (238)
56 PF11947 DUF3464: Protein of u 27.5 3.5E+02 0.0076 22.3 7.5 24 48-71 63-86 (153)
57 PRK11111 hypothetical protein; 26.6 4.4E+02 0.0095 23.1 9.3 61 333-397 28-88 (214)
58 PF14184 YrvL: Regulatory prot 26.5 3.4E+02 0.0073 21.7 13.0 101 132-234 7-108 (132)
59 PF15461 BCD: Beta-carotene 15 26.4 4.9E+02 0.011 23.5 14.9 21 424-444 162-182 (259)
60 TIGR00383 corA magnesium Mg(2+ 26.2 3.3E+02 0.0071 25.3 7.9 21 233-253 297-317 (318)
61 TIGR00427 membrane protein, Ma 23.6 4.8E+02 0.01 22.5 9.3 62 332-397 24-85 (201)
62 COG0798 ACR3 Arsenite efflux p 23.4 6.4E+02 0.014 23.9 14.5 26 225-250 303-328 (342)
63 PF04505 Dispanin: Interferon- 23.2 2.9E+02 0.0063 19.8 6.5 34 111-144 42-75 (82)
64 PRK10995 inner membrane protei 22.2 5.4E+02 0.012 22.6 8.7 59 333-395 26-84 (221)
65 KOG3832 Predicted amino acid t 20.6 1.2E+02 0.0026 26.2 3.2 13 83-95 159-171 (319)
No 1
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=100.00 E-value=2.7e-50 Score=393.44 Aligned_cols=383 Identities=25% Similarity=0.338 Sum_probs=358.5
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 013357 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (444)
Q Consensus 44 ~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~ 123 (444)
.++..|+++++++|.+++++...+++.+|+.++||+|++++|+.+++.++.. +...+..|++.+..+.++|++|+||++
T Consensus 12 ~~~~~k~l~~la~P~i~~~l~~~l~~~vD~~~vG~~~~~alaav~la~~i~~-~~~~~~~gl~~g~~~liaq~~Ga~~~~ 90 (455)
T COG0534 12 FKKILKLLLKLAIPIILGNLLQTLYGLVDTFMVGHLGAEALAAVGLANPIFF-LIIAIFIGLGTGTTVLVAQAIGAGDRK 90 (455)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHH-HHHHHHHHHHHhHHHHHHHHHcCCchH
Confidence 5678999999999999999999999999999999999999999999999999 899999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHH
Q 013357 124 MLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAY 202 (444)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 202 (444)
++++..++++.++++++++.. +.+.+.++++.+++.++|+.+.+.+|+++..++.|+..+..+..+.+|+.||+|.++.
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~m~ 170 (455)
T COG0534 91 KAKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSFVLSGILRGLGDTKTPMY 170 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCchhHH
Confidence 999999999999999997776 6788999999999998899999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHh-cC-CccchhHHHHHHHHHHHHHHHHHHHHhccc-ccccccccchhhhhhHHHHHHHHhHH
Q 013357 203 ISAATLVLHLLLSWLVVYK-FG-AGLIGASLVLSLSWYIIVGAQFAYILMSDK-CKHTWTGFSVQAFSGICEFLKLSGSS 279 (444)
Q Consensus 203 ~~~~~~i~~i~l~~ili~~-~~-~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~p~ 279 (444)
.++++.++|+++|++|+++ ++ +|+.|+++||.+++.+..++..++++|+++ ......+..+.+++.+|++++.|+|.
T Consensus 171 ~~~~~~~lNivln~llI~g~~g~lGv~GAA~AT~ia~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lG~p~ 250 (455)
T COG0534 171 ILLLGNLLNIVLNYLLIFGLFGGLGVAGAALATVIARWIGALLLLIYLLRKKRLLSLFKKKLLKPDRKLLKEILRLGLPI 250 (455)
T ss_pred HHHHHHHHHHHhhHHHHHhccccccchhHHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhccCCCHHHHHHHHHhcccH
Confidence 9999999999999999998 67 999999999999999999999999988754 22222223233347799999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHH
Q 013357 280 AVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISF 359 (444)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 359 (444)
++.+..+...+...+.+++++|++ ++|+|+++.++.++.++++.|++++..|+++|++|++|++++++..+.++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~G~~--~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvG~~~Ga~~~~~a~~~~~~~~~~~~ 328 (455)
T COG0534 251 FLESLSESLGFLLLTLFVARLGTV--ALAAYGIALRIASFIFMPPFGIAQAVTILVGQNLGAGNYKRARRAARLALKLSL 328 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHhcChH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHH
Confidence 999999999999999999999954 456999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcc
Q 013357 360 IISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWN 429 (444)
Q Consensus 360 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~ 429 (444)
++++..+++++++++++.++|++|+|+.+.+.+++++.++..++++.+.+..+.+||.||++.+.+....
T Consensus 329 ~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g~lrg~g~~~~~~~~~~~ 398 (455)
T COG0534 329 LIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSGVLRGAGDAKIPFIISLL 398 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999999999999998887555544
No 2
>PRK10189 MATE family multidrug exporter; Provisional
Probab=100.00 E-value=7.9e-46 Score=365.38 Aligned_cols=383 Identities=15% Similarity=0.154 Sum_probs=347.3
Q ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCC
Q 013357 42 IASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGR 121 (444)
Q Consensus 42 ~~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~ 121 (444)
...-+..|++++.++|.++++++..+...+|+.+++++|++++|+++++.++.. +...+..|++++..+.++|++|+||
T Consensus 22 ~~~~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~lG~~alAA~~i~~~i~~-~~~~~~~gl~~g~~~lvsq~~Ga~~ 100 (478)
T PRK10189 22 SYRVLFWREITPLAVPIFIENLCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNM-VIMAFFAAIDLGTTVVVAFSLGKRD 100 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 344556999999999999999999999999999999999999999999999998 8889999999999999999999999
Q ss_pred cchHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcC--CCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCch
Q 013357 122 YEMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLG--ESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVL 198 (444)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~--~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~ 198 (444)
+|++++..++++.++..++++.. +.+.+.++++.++. .|+|+.+.+.+|+++..++.|+..+....++.+|+.||++
T Consensus 101 ~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~ 180 (478)
T PRK10189 101 RRRARAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAITLIGSGALRGAGNTK 180 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCchH
Confidence 99999999999999999999887 45778899999984 6899999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhc----CCccchhHHHHHHHHHHHHHHHHHHHHhc-c-cccccccc-cchhhhhhHHH
Q 013357 199 PSAYISAATLVLHLLLSWLVVYKF----GAGLIGASLVLSLSWYIIVGAQFAYILMS-D-KCKHTWTG-FSVQAFSGICE 271 (444)
Q Consensus 199 ~~~~~~~~~~i~~i~l~~ili~~~----~~g~~g~~~a~~i~~~i~~~~~~~~~~~~-~-~~~~~~~~-~~~~~~~~~~~ 271 (444)
.++..+++..++|+++++++++.+ ++|+.|+++|+.+++.+..++..+++.++ + ..+.++++ +.+.+++.+|+
T Consensus 181 ~~~~i~~~~~~~ni~l~~~li~g~~~~~~lGv~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (478)
T PRK10189 181 IPLLINGGMNILNIIISSILIYGLFSWQGLGFVGAGLGLTISRYIGAVAIIWVLMIGFNPALRISLKSYFKPLNFAIIWE 260 (478)
T ss_pred HhHHHHHHHHHHHHHHhHHHHhcCCCCCccchHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeeccccccCCHHHHHH
Confidence 999999999999999999999853 68999999999999999988877666543 1 22222222 22223467999
Q ss_pred HHHHHhHHHHHHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHH
Q 013357 272 FLKLSGSSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSV 351 (444)
Q Consensus 272 i~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~ 351 (444)
+++.|+|.++..........+.+.+++++|+. ++|+|+++.++.++.+++..|++++..|+++|++|++|++++|+..
T Consensus 261 il~iG~P~~~~~~~~~~~~~~~~~~~~~~G~~--~~Aa~~I~~~i~~~~~~~~~gi~~A~~~lvg~~~Ga~~~~~a~~~~ 338 (478)
T PRK10189 261 VMGIGIPASIESVLFNGGKLLTQMFVAGMGTS--VIAGNFIAFSIAALINLPGNALGSASTIITGTRLGKGQIAQAERQL 338 (478)
T ss_pred HHHHhccHHHHHHHHHHHHHHHHHHHHHcCHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHH
Confidence 99999999999999998888888889999954 5669999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhh
Q 013357 352 VVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMK 427 (444)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~ 427 (444)
+.+.++++++++..+++++++++++.++|++|+|+.+.+...+++.++..++++.+.+..+.+||.||++++++..
T Consensus 339 ~~~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g~lrg~G~t~~~~~i~ 414 (478)
T PRK10189 339 RHVFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPAGLKGARDARYAMWVS 414 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHhhcCCCchHHHHHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999988875443
No 3
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=100.00 E-value=8.4e-46 Score=365.13 Aligned_cols=386 Identities=24% Similarity=0.276 Sum_probs=348.2
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 43 ~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
+++++.|++++.++|.++++++..+...+|+.+++|+|++++++++++.++.+ +...+..|++++..+.++|++|+||+
T Consensus 4 ~~~~~~k~il~~a~P~~~~~~~~~~~~~~d~~~v~~lg~~alAa~~i~~~i~~-~~~~~~~gl~~~~~~i~aq~~Ga~~~ 82 (464)
T PRK00187 4 PPTTELKAILRLAGPLIASQLAHMLMVFTDTLMMGRLGPEALAGGGLGAASYS-FVSIFCVGVIAAVGTLVAIRHGAGDI 82 (464)
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCCh
Confidence 35678999999999999999999999999999999999999999999999999 77888999999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHH
Q 013357 123 EMLGVYMQRATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAY 202 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 202 (444)
|++++.+++++.+..+++++..++..+.++++.+++.|+|+.+.+.+|+++..++.|+..+....++++|+.||++.+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 162 (464)
T PRK00187 83 EGATRLAQAGLWLAWLLALVAALLLWNLKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMALRGFTSALGRAGPVMV 162 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHH
Confidence 99999999999999999988776555779999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhc----CCccchhHHHHHHHHHHHHHHHHHHHHhcccc-ccc-ccccchhhhhhHHHHHHHH
Q 013357 203 ISAATLVLHLLLSWLVVYKF----GAGLIGASLVLSLSWYIIVGAQFAYILMSDKC-KHT-WTGFSVQAFSGICEFLKLS 276 (444)
Q Consensus 203 ~~~~~~i~~i~l~~ili~~~----~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~i~~~~ 276 (444)
.++++.++|+++++++++.. ++|+.|+++|+.+++....+...++++++++. +.+ ++++.+.+++.+|++++.+
T Consensus 163 ~~~~~~~~ni~~~~~lIfg~~g~p~~Gv~Gaalat~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~lg 242 (464)
T PRK00187 163 ISLAGAVANLLLNYALIEGWFGLPKLGLMGIGLVTALVSNGMALALALYIRRHPAYAAYPLRKGLSRPSRAALRELWRLG 242 (464)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCccccccchHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhccccCCCHHHHHHHHHhh
Confidence 99999999999999999753 38999999999999988877776666654322 111 1112222346699999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHH
Q 013357 277 GSSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTS 356 (444)
Q Consensus 277 ~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~ 356 (444)
+|.+++++.+...+.++..+++++|+. ++|++++++++..+.+.+..|++.+..+.++|++|++|++++++..+.++.
T Consensus 243 ~P~~~~~~~~~~~~~i~~~~i~~~G~~--alAa~~i~~~i~~l~~~~~~gi~~a~~~lvgq~~Ga~~~~~~~~~~~~~l~ 320 (464)
T PRK00187 243 LPIGGTYAVEVGLFTFAALCMGALGST--QLAAHQIALQIVSVAFMVPVGLSYAVTMRVGQHYGAGRLLEARRAGRVGIG 320 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHcCHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHH
Confidence 999999999999999999999999964 566999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHhhhhhhhhccC--cH---HHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccc
Q 013357 357 ISFIISVVFAVIVLALRHVISYAFTS--GE---VVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNS 431 (444)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~l~~l~~~--~~---~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~ 431 (444)
++++++++.+++++++++++.++|++ |+ |+.+.+..++++.+++.++++++.+..+++||.||++++.+......
T Consensus 321 ~~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~~lrg~G~~~~~~~~~~~~~ 400 (464)
T PRK00187 321 FGAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMGAIRGLKDARTTFLIGLACY 400 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHHhHhccCccHHHHHHHHHHH
Confidence 99999999999999999999999964 44 67888999999999999999999999999999999998866655443
No 4
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=100.00 E-value=1.5e-45 Score=360.07 Aligned_cols=379 Identities=17% Similarity=0.149 Sum_probs=334.8
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 013357 45 WLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (444)
Q Consensus 45 ~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~l-g~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~ 123 (444)
.++.|++++.++|.++++++..+.+.+|+.+++++ |++++|+++++.++.. +...+..+++.+..+.+||++|+||+|
T Consensus 5 ~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~g~~alAa~~l~~~i~~-~~~~~~~~~~~g~~~lvsq~~Ga~~~~ 83 (441)
T PRK10367 5 TSSDKALWRLALPMIFSNITVPLLGLVDTAVIGHLDSPVYLGGVAVGATATS-FLFMLLLFLRMSTTGLTAQAFGAKNPQ 83 (441)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 45689999999999999999999999999999998 7789999999999999 788888999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHH
Q 013357 124 MLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAY 202 (444)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 202 (444)
++++..++++.++++++++.. +...+.++++.+++.|+|+.+.+.+|+++..++.|+..+..+..+.+|+.||++.++.
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 163 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPVI 163 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHHH
Confidence 999999999999999998887 4567888999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhccccc-ccccccchhhhhhHHHHHHHHhHHHH
Q 013357 203 ISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCK-HTWTGFSVQAFSGICEFLKLSGSSAV 281 (444)
Q Consensus 203 ~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~p~~~ 281 (444)
.++++.++|+++++++++.+++|+.|+++|+.+++.+..+...+++.++++.+ .+.+.++.+.++.+|++++.+.|.++
T Consensus 164 ~~ii~~~vni~l~~~lI~~~~lGv~Gaa~At~is~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~ig~P~~~ 243 (441)
T PRK10367 164 LLVVGNILNIVLDLWLVMGLHMNVQGAALATVIAEYATLLIGLLMVRKVLKLRGISLEMLKTAWRGNFRRLLALNRDIML 243 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCccHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHhhhhhHHHHHHHHHhCchHHH
Confidence 99999999999999999988899999999999999999888777776542222 11111222212468999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHH
Q 013357 282 MLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFII 361 (444)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 361 (444)
....+...+.+.+.+++++|+. ++|+|+++.++.++.+++..|++++..|.++|++|++|++++|+..+.++++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~G~~--alAa~~I~~~i~~~~~~~~~gl~~a~~~lvg~~~Ga~~~~~a~~~~~~~~~~~~~~ 321 (441)
T PRK10367 244 RSLLLQLCFGAITVLGARLGSD--IIAVNAVLMTLLTFTAYALDGFAYAVEAHSGQAYGARDGSQLLDVWRAACRQSGIV 321 (441)
T ss_pred HHHHHHHHHHHHHHHHHhcCHH--HHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999964 56799999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHH----HhhhhhhchhhHHHHHHhh
Q 013357 362 SVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQP----VLSGPYMHIFLIFFTCVMK 427 (444)
Q Consensus 362 ~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~----~~~~~l~~~g~~~~~~~~~ 427 (444)
+.+.+++++++++++.++|++|+|+.+.+.+++++.++..+...... +.++.++|. |++++.+..
T Consensus 322 ~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~g~lrg~-dt~~~~~~~ 390 (441)
T PRK10367 322 ALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVILPLVGVWCYLLDGMFIGATRAA-EMRNSMAVA 390 (441)
T ss_pred HHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCccchH-HHHHHHHHH
Confidence 99999999999999999999999999999999999886533222333 355555554 677664433
No 5
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=100.00 E-value=4.3e-45 Score=359.53 Aligned_cols=389 Identities=16% Similarity=0.203 Sum_probs=351.9
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 44 ~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~l-g~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
+++..|++++.++|.+++++...+++.+|+.+++++ |++++++++++.++.. +...+..+++.+..+.++|++|+||+
T Consensus 7 ~~~~~k~i~~l~~P~~~~~l~~~l~~~~d~~~lg~~~g~~~laa~~~~~~~~~-~~~~~~~~~~~g~~~lvsq~~Ga~~~ 85 (453)
T PRK09575 7 NQSIYRTFWRYTIPSIAAMLVNGLYQIVDGIFIGHYVGAEGLAGINMAWPVIG-IILGIGLMVGMGTGSLLSIKRGEGDL 85 (453)
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHHHHH-HHHHHHHHHhccHHHHHHHHhcCCCH
Confidence 345789999999999999999999999999999995 9999999999999999 77788889999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHH
Q 013357 123 EMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 201 (444)
|++++.+++++.++.+++++.. ++..+.++++.+++.|+++.+.+.+|+++..++.++..+.....+.+|+.||++.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~ 165 (453)
T PRK09575 86 EKAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAIALPFLLRNDESPNLAT 165 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 9999999999999999998887 567799999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhccc-ccccccccchhhhhhHHHHHHHHhHHH
Q 013357 202 YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDK-CKHTWTGFSVQAFSGICEFLKLSGSSA 280 (444)
Q Consensus 202 ~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~p~~ 280 (444)
..++.+.++|+++++++++.+++|+.|+++|+.+++++..+..+++++++++ .+.+.+.++. +++.+|++++.|.|.+
T Consensus 166 ~~~~~~~~~ni~l~~~li~~~~~Gi~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~il~ig~P~~ 244 (453)
T PRK09575 166 GLMVIGALINIVLDYLFIGWLDWGLTGAAIATALAQLVVTVLGLGYFFSSRANIRLTLKELRF-NWSLAPKIVLLGSSSF 244 (453)
T ss_pred HHHHHHHHHHHHhhHHHHHhCCchhHHHHHHHHHHHHHHHHHHHHHHHCCCceeEEeeccCCc-CHHHHHHHHHhChhHH
Confidence 9999999999999999999888999999999999999999988877765533 2222222222 2456899999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH
Q 013357 281 VMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFI 360 (444)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 360 (444)
+......+...+...+.+++|+. .++|+|+++.++..+.+.+..|++++..|.++|++|+||+|++++..+.++++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~g~~-~~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvg~~~Ga~~~~~~~~~~~~~l~l~~~ 323 (453)
T PRK09575 245 FMYLYGSFVVALHNRLFMEYGSA-LTVGAYAIVGYLMVLYYLVAEGIAEGMQPPVSYYFGARQYDNIKKLLKLAMKVTVL 323 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHhCch-HHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHhcCCChHHHHHHHHHHHHHHHH
Confidence 99999999999988889898863 34679999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhhhhhhhhccC-cHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhhH
Q 013357 361 ISVVFAVIVLALRHVISYAFTS-GEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIHL 435 (444)
Q Consensus 361 ~~~~~~~~~~~~~~~l~~l~~~-~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~ 435 (444)
.+++.+++++.+++++.++|++ |||+.+.+.+++++.+++.++++++.+..+.+||.||++.+.+.......+++
T Consensus 324 ~~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~v~i 399 (453)
T PRK09575 324 AGIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLASAYFMAVNQGGKALFISIGNMLIQL 399 (453)
T ss_pred HHHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHHHHHHhHHHHH
Confidence 9999999999999999999985 78999999999999999999999999999999999999888665554434443
No 6
>PRK01766 multidrug efflux protein; Reviewed
Probab=100.00 E-value=5.9e-44 Score=353.02 Aligned_cols=386 Identities=21% Similarity=0.305 Sum_probs=350.2
Q ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCC
Q 013357 42 IASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGR 121 (444)
Q Consensus 42 ~~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~ 121 (444)
+..++.+|++++.++|.+++++...+...+|+.+++++|++++++++++.++.. ....+..|++++..+.+||++|++|
T Consensus 5 ~~~~~~~~~il~~~~P~~~~~~~~~~~~~~d~~~i~~~g~~~laa~~~~~~~~~-~~~~~~~g~~~a~~~~vs~~~g~~~ 83 (456)
T PRK01766 5 QKYKSEARQLLALALPILLAQVAQTAMGFVDTVMAGGVSATDLAAVAIGTSIWL-PVILFGHGLLLALTPIVAQLNGAGR 83 (456)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 345678999999999999999999999999999999999999999999999877 6778889999999999999999999
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHH-HHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHH
Q 013357 122 YEMLGVYMQRATFVLLATGVPVMM-VYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPS 200 (444)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 200 (444)
+++.++.++++..+++..++++.+ ++.+.++++.+++.|+++.+.+.+|+++.+++.++..+..+.++++++.||++.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 163 (456)
T PRK01766 84 RERIAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQVLRSFIDGLGKTKPT 163 (456)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHH
Confidence 999999999999999999988874 5677889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHh----cCCccchhHHHHHHHHHHHHHHHHHHHHhccccc--ccccccchhhhhhHHHHHH
Q 013357 201 AYISAATLVLHLLLSWLVVYK----FGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCK--HTWTGFSVQAFSGICEFLK 274 (444)
Q Consensus 201 ~~~~~~~~i~~i~l~~ili~~----~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~ 274 (444)
++.++++.++|+++++++++. .++|+.|+++++.+++++..++..++++++++.+ +.+.++.+..++.+|++++
T Consensus 164 ~~~~~i~~ivni~l~~~li~~~~~~~~~Gv~Gaa~at~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~ 243 (456)
T PRK01766 164 MVIGFLGLLINIPLNYIFIYGKFGFPELGGVGCGVATAIVYWVMFLAMLIYIKRARRFRDFRLFKGLYKPDWAVIKRLLK 243 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCcccccccHHHHHHHHHHHHHHHHHHHHHhChhhhHHHhhccccCCCHHHHHHHHH
Confidence 999999999999999999864 2479999999999999999998888776653321 1122222233466999999
Q ss_pred HHhHHHHHHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHH
Q 013357 275 LSGSSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVV 354 (444)
Q Consensus 275 ~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~ 354 (444)
.++|.+++...+...+.++..+++++|+.+ +++++++.++.++.+.++.|++.+..+.++|++|++|++++++..+.+
T Consensus 244 l~~P~~~~~~~~~~~~~~~~~~~~~~G~~~--lAa~~i~~~i~~~~~~~~~gl~~a~~~~v~~~~Ga~~~~~~~~~~~~~ 321 (456)
T PRK01766 244 LGLPIGLAIFFEVSLFAVVTLLVSPLGTVT--VAAHQIALNFSSLLFMLPLSLAMALTIRVGFELGAGRTLDARQYAYIG 321 (456)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHcChHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCHHHHHHHHHHH
Confidence 999999999999999999999999999644 569999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhccc
Q 013357 355 TSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNN 430 (444)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~ 430 (444)
+++++.++++.+++++.+++++.++|++|||+.+.+..++++..+..++++++.+.++++||.||++.+.......
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~~l~g~g~~~~~~~~~~~~ 397 (456)
T PRK01766 322 LAVGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSGALRGYKDTRVIFFITFIA 397 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhchhccCccHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999988886655543
No 7
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=100.00 E-value=4.1e-37 Score=293.41 Aligned_cols=338 Identities=32% Similarity=0.563 Sum_probs=307.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHH
Q 013357 57 PAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVL 136 (444)
Q Consensus 57 p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 136 (444)
|.++++++..+...+|+.+++++|++++++++++.++.. +...+..|++++..+.+++++|++|+|+.++.+++...+.
T Consensus 1 p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~a~~i~~-~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 79 (342)
T TIGR00797 1 PAILANILQPLLGLVDTAFVGHLGPVDLAAVSLGSSVFM-FLFSILMGLGTATTALVAQAVGAGNYQRLGRQAQQSLLLA 79 (342)
T ss_pred ChHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHhHHHHH-HHHHHHHHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHHH
Confidence 788999999999999999999999999999999999888 8888999999999999999999999999999999999999
Q ss_pred HHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHH
Q 013357 137 LATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLS 215 (444)
Q Consensus 137 ~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~~i~l~ 215 (444)
.+.+++.. +++.+.+++..+++.+++..+.+..+++++.+..++..+..+..+.+++.||++.+...++++.+++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~~~~~i~~~ 159 (342)
T TIGR00797 80 LLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIGNVINIILN 159 (342)
T ss_pred HHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHHHHHHHh
Confidence 99999987 56778899999888788888999999999999999999999999999999999999999999999999999
Q ss_pred HHHHH-hcC-CccchhHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHHHHHHHHHHHHHH
Q 013357 216 WLVVY-KFG-AGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYFQIL 293 (444)
Q Consensus 216 ~ili~-~~~-~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~~~ 293 (444)
+++++ .++ +|+.|+++++.+++++..++..++.+|+++.+.++++..+..++.+|+++++++|..+......+...++
T Consensus 160 ~~li~~~~g~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~P~~~~~l~~~~~~~~~ 239 (342)
T TIGR00797 160 YILIFGKFGFLGIVGAALATVISYWLMFLLLLYYIKKAKKIGLKWEGLLKPDWEVLKRLLKLGLPIAFRVILESLSFALL 239 (342)
T ss_pred HHHHhcCccccccHHHHHHHHHHHHHHHHHHHHHHHhCCCcccccccccCCCHHHHHHHHHhCchHHHHHHHHHHHHHHH
Confidence 99987 667 8899999999999999999888777764444433222122224569999999999999999999999999
Q ss_pred HHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 013357 294 VLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALR 373 (444)
Q Consensus 294 ~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (444)
+.+++.+|++ ++++|+++.++.++...++.+++.+..|.++++++++|.++.++..++++++.++++++.++++.+++
T Consensus 240 ~~i~~~~g~~--~v~~~~~a~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 317 (342)
T TIGR00797 240 ALLVARLGSI--ALAAHQIALNVESLLFMPAFGFGIAVSILVGQALGAGDPKRAKEVARVALKLSLLLGLVLAIILILFR 317 (342)
T ss_pred HHHHHHcCcH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999998854 45699999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhccCcHHHHHHHHHHhHHH
Q 013357 374 HVISYAFTSGEVVANAVSELCPLL 397 (444)
Q Consensus 374 ~~l~~l~~~~~~~~~~~~~~l~i~ 397 (444)
+++.++|++|||+.+.+..++++.
T Consensus 318 ~~i~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T TIGR00797 318 EFIARLFTNDPEVLELAAIYLIFV 341 (342)
T ss_pred HHHHHHhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999888764
No 8
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=100.00 E-value=5.4e-33 Score=269.46 Aligned_cols=387 Identities=44% Similarity=0.734 Sum_probs=367.8
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcch
Q 013357 45 WLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEM 124 (444)
Q Consensus 45 ~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~ 124 (444)
..+.|++.+++.|.++..+.......+++.++||+|+.++++.+++.+..+.....+..|+.++..++++|++|.++++.
T Consensus 24 ~~e~k~l~~ia~P~i~~~~~~~~~~~is~~f~GhlG~leLaa~sla~s~~n~~~~s~~~gl~~aletlcgQa~ga~~~~~ 103 (473)
T KOG1347|consen 24 VTESKELARLALPAILTFLAQPLLSLVSTAFAGHLGNLELASVSLANSFANITGVSILLGLQLALDTLCGQAFGAKKFTA 103 (473)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHhhhccccchHHHHHHHHHHhhcccchHHhhccchhhhcchHhhhcccccch
Confidence 68899999999999999999999999999999999999999999999999977889999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHH
Q 013357 125 LGVYMQRATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYIS 204 (444)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~ 204 (444)
.....+++..+....+++..+++.+.++++..+++++++...+..|.+...+..+..........+++++++.....+..
T Consensus 104 lg~~lqrs~~~l~~~~~~~~~l~~~~~~il~~lgq~~~i~~~a~~y~~~~ip~~~a~~~~~~l~~~lq~Q~~~~~~~~~~ 183 (473)
T KOG1347|consen 104 LGVYLQRSGIVLLVQGLPISLLILNSEPILLLLGQDPDISRDAGSYAFMLIPGLFSYAVSFPLAKFLQAQSITLPLLVIG 183 (473)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHccHHHHHHhCCChhHHHHHhhhHhhhcchhhhhHHHHHHHHHHHhccCchHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHHHHH
Q 013357 205 AATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLC 284 (444)
Q Consensus 205 ~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~ 284 (444)
....++++.+++++++..++|..|++++..++++........+..... ....|..++.+ ++.++++++.++|..++..
T Consensus 184 ~~~~~lhi~~~~llv~~~~~g~~Gaala~~~s~w~~~~~l~~yi~~~~-~~~~w~~~s~~-~~~~~~~~~lai~s~~mic 261 (473)
T KOG1347|consen 184 LVALVLHILLTWLLVSKLGLGIKGAALALVASYWLNVRILLLYAVLSG-CLAAWSGFSGE-FDSWGPFFALAIPSAVMIC 261 (473)
T ss_pred HHHHHHHHHHHHHhhhcccCCCccchHHHHHHHHHHHHHHHHHheecC-chhhhhhhhHh-hhhHHHHHHHhhcchheeH
Confidence 999999999999999999999999999999999999999988887664 56678888888 8999999999999999999
Q ss_pred HHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHH
Q 013357 285 LETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVV 364 (444)
Q Consensus 285 ~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 364 (444)
.+++.+....+..+.++++...+++.++..++....++++.+++.+.+.++++.+|+++++++|...+.....++..++.
T Consensus 262 lE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~~~~~~~~~~~a~strv~neLGag~p~~ar~~~~v~~~~~~~~g~~ 341 (473)
T KOG1347|consen 262 LEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGWHLMIPGAFSAAVSTRVSNELGAGKPKRARVSAKVALQTSVAIGAS 341 (473)
T ss_pred HHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHcCCChhhhhhHHHHHHHHHHHHHHH
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhhHHHHHh
Q 013357 365 FAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIHLLCYNQ 440 (444)
Q Consensus 365 ~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~ 440 (444)
.+..+...++.+..+|++|+|+.+...+..++++...++++.+.+..++.+|.|. +-+.+.+++.+|++
T Consensus 342 ~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v~~Gva~g~g~-------q~~ga~vnl~~yyl 410 (473)
T KOG1347|consen 342 LGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAVLSGVARGSGW-------QQIGAVINLVAYYL 410 (473)
T ss_pred HHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhhhhheEEeecc-------ccceEEEeeeeeeE
Confidence 9999999999999999999999999999999999999999999999999999997 55555566655554
No 9
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=100.00 E-value=1.3e-31 Score=268.70 Aligned_cols=380 Identities=13% Similarity=0.077 Sum_probs=312.0
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHH-HHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhcCCCcchHHH
Q 013357 51 LVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLEL-AAASLGNSGIQLFAYGLM-LGMGSAVETLCGQAYGAGRYEMLGV 127 (444)
Q Consensus 51 il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~-a~~~~a~~~~~~~~~~~~-~gl~~~~~~~~s~~~g~~~~~~~~~ 127 (444)
+.|.+.-.++++++..+.+++|..++++ +|++++ ++++.+.++...+..... .|++++..+...++.+++ |+.++
T Consensus 2 ~~k~~~i~~~~~~~~~~~~~~~~~~~a~~lG~~~~~~~~~~~~~i~~~~~~~~~~~g~~~a~i~~~~~~~~~~--~~~~~ 79 (502)
T TIGR01695 2 LLKSTLIVSLGTLFSRITGFVRDAIIASAFGAGLTADAFNVAFVIPNFFRRLFAEGAFNSAFVPVFTKAKKKE--KEARR 79 (502)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChHhhHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhh--hHHHH
Confidence 5677888999999999999999999999 799999 899999999873333333 468888777776654332 57777
Q ss_pred HHHHHHHHHHHHHHH-HH-HHHHhhHHHHHHc--CCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHH
Q 013357 128 YMQRATFVLLATGVP-VM-MVYIFCKPMLILL--GESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYI 203 (444)
Q Consensus 128 ~~~~~~~~~~~~~~~-~~-~~~~~~~~i~~~~--~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 203 (444)
.+.++.......+.. .. +.+.+.+++..++ +.+++..+.+.+|++++.++.++..+....++++|+.||.+.++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 159 (502)
T TIGR01695 80 AFANTVTTLLILSLLLVVLIGIFFAPFVISLLAPGFADETRSLAVSLTRIMFPYLLLISLAAVFGGILNARKRFFIPSFS 159 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeeHHHHHH
Confidence 777766666554444 34 4567778888877 4567777889999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCccchhH--HHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHH
Q 013357 204 SAATLVLHLLLSWLVVYKFGAGLIGAS--LVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAV 281 (444)
Q Consensus 204 ~~~~~i~~i~l~~ili~~~~~g~~g~~--~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~ 281 (444)
+++..+++++..+++ ..++|..|++ +++.++..+..++.+++.+|++ .+.+ .+++.+ ++.+|++++.+.|..+
T Consensus 160 ~i~~~i~~i~~~~~~--~~~~g~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~-~~~~~~-~~~~k~~l~~~~p~~~ 234 (502)
T TIGR01695 160 PILFNIGVILSLLFF--DWNYGQYSLALAIGVLIGGVAQLLIQLPFLRKAG-FLLK-PRFNFR-DPGLKRFLKLFLPTTL 234 (502)
T ss_pred HHHHHHHHHHHHHHH--HcccchHHHHHHHHHHHHHHHHHHHHHHHHHHCC-Cccc-CcCCCC-ChhHHHHHHHHHHHHH
Confidence 999988776643333 3368999988 9999999999888877776542 1111 122222 3568999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH
Q 013357 282 MLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFM-VSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFI 360 (444)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~-~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 360 (444)
......+...++..+.+.+|+++ +++|+.+.++..++.. +..+++++..|.+++++|++|++++++..++++++...
T Consensus 235 ~~~~~~~~~~id~~~~~~~~~~~--v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~~~~~~~~~~~~~~~~ 312 (502)
T TIGR01695 235 GSSASQITLLINTALASFLEIGS--VSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWNELRDLLNQGIRLSLL 312 (502)
T ss_pred HHHHHHHHHHHHHHHHhcCCcch--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHH
Confidence 99999999999998877777544 5599999999988765 67899999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhhhhhhhhccC----cHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhhHH
Q 013357 361 ISVVFAVIVLALRHVISYAFTS----GEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIHLL 436 (444)
Q Consensus 361 ~~~~~~~~~~~~~~~l~~l~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~ 436 (444)
++++.++++.++++++.++|.+ |+|..+.+.++++++++..++.+++.++.+.+++.||++...........+++.
T Consensus 313 ~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~~~~~~~~~~~~i~i~ 392 (502)
T TIGR01695 313 LTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTRTPFINSVISVVLNAL 392 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCccCHHHHHHHHHHHHH
Confidence 9999999999999999999865 567788899999999999999999999999999999999887766666666654
Q ss_pred HHH
Q 013357 437 CYN 439 (444)
Q Consensus 437 ~~~ 439 (444)
..+
T Consensus 393 l~~ 395 (502)
T TIGR01695 393 LSL 395 (502)
T ss_pred HHH
Confidence 433
No 10
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=100.00 E-value=2.5e-31 Score=265.86 Aligned_cols=378 Identities=12% Similarity=0.124 Sum_probs=311.9
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHH
Q 013357 52 VRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQ 130 (444)
Q Consensus 52 l~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~~~~ 130 (444)
.|.+.|.++++++..+.+++|+.+++| +|++++|+++.+.++..+.......|++++..+.++|+.|++|+++.++.++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~~~l~r~Lg~~~~G~~~~~~~~~~~~~~~~~~Gl~~a~~~~is~~~~~~~~~~~~~~~~ 81 (488)
T TIGR02900 2 LKGTFILTIANLITRILGFIFRIVLSRILGAEGVGLYGMAMPIYFLFITLTTGGLPVAISKFVAEASAKNDRKNIKKILK 81 (488)
T ss_pred hHhHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhhHHHHHHHHHHHHHHHHhCCcHHHHHHHHHHHHhccchhhHHHHHH
Confidence 467899999999999999999999999 6999999999999998844444557999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHH-HHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHH
Q 013357 131 RATFVLLATGVPVMM-VYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLV 209 (444)
Q Consensus 131 ~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i 209 (444)
+++.+..+.+++..+ ++.+.+++...+..+++.. .++++..+..++..+....++.+|+.+|.+..+..+.++.+
T Consensus 82 ~~~~l~l~~~~~~~~l~~~~~~~i~~~~~~~~~~~----~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~i~~i 157 (488)
T TIGR02900 82 VSLIFTLIWSLIVTAIVFLLSPFIASTLLKDERSL----YSLLVICPAMPFIALSSVLKGYFQGISNMKPPAYIQVIEQI 157 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHcCChhHH----HHHHHHHHHHHHHHHHHHHHHHHhhhccchHhHHHHHHHHH
Confidence 999999999988874 4566777666666665432 46788889999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhc-----CCccchhHHHHHHHHHHHHHHHHHHHHhccccccc--ccccchhhhhhHHHHHHHHhHHHHH
Q 013357 210 LHLLLSWLVVYKF-----GAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHT--WTGFSVQAFSGICEFLKLSGSSAVM 282 (444)
Q Consensus 210 ~~i~l~~ili~~~-----~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~~~p~~~~ 282 (444)
+++.++..++..+ +.|+.|+++++.++..+..+...++++|+++.+.+ +.+..+..++.+|+++++++|..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~v~g~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~l~~~~~p~~l~ 237 (488)
T TIGR02900 158 VRISVVALLISAFLPYGLEYAVAGAYLSLVLGELVSLLYLYFFFKRKKSFSIRFPFFDYKSEGKALLFDLFSVSLPLTLS 237 (488)
T ss_pred HHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccCcchHHHHHHHHHHHHHHHHH
Confidence 9987766665432 35678888999999999988877766554332211 1111222245699999999999999
Q ss_pred HHHHHHHHHHHHHHHhhc----Cc-hHH---HHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHH
Q 013357 283 LCLETWYFQILVLIAGLL----DN-PEL---ALDSL-SVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVV 353 (444)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~----g~-~~~---~va~~-~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~ 353 (444)
++...+...+|..++++. |. ... .++.| +++.++..++..+..+++++..|.++++.|++|+++.++..++
T Consensus 238 ~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~~~~~~~l~~~~~p~~s~~~~~~~~~~~~~~~~~ 317 (488)
T TIGR02900 238 RFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFPAVITSSLSTALVPDISEAMAKKNYSSIEKRINQ 317 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence 999999999999888653 21 111 22233 4566778888888999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchh
Q 013357 354 VTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKI 433 (444)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~ 433 (444)
++++...++.|.++++..+++++..++.++++ +.++++++++..++.+++.+..+.+++.||++...........+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~----~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~ 393 (488)
T TIGR02900 318 AIKISLLLGLITTVILLVIPDELGALFYGRPD----AGNFIRVLAPSFPFLYFSAPLQSILQGLGKQKVALRNSLIGAIV 393 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCc----hHHHHHHHHHHHHHHHHHHHHHHHHHhcCcchHHHHHHHHHHHH
Confidence 99999999999999999999999999876544 57789999999999999999999999999999887776666666
Q ss_pred hHHH
Q 013357 434 HLLC 437 (444)
Q Consensus 434 ~~~~ 437 (444)
++..
T Consensus 394 ~i~l 397 (488)
T TIGR02900 394 KIIL 397 (488)
T ss_pred HHHH
Confidence 6543
No 11
>PRK15099 O-antigen translocase; Provisional
Probab=99.98 E-value=1.8e-28 Score=239.80 Aligned_cols=369 Identities=11% Similarity=0.020 Sum_probs=299.1
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHH
Q 013357 51 LVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYM 129 (444)
Q Consensus 51 il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~~~ 129 (444)
+.|.+.....+..+..+.+++...+++| +|++++|.++...++...+......|++++..+.++|+ ++|+++.++.+
T Consensus 3 ~~k~~~~~~~~~~~~~~~~~l~~~i~ar~Lg~~~~G~~~~~~~~i~~~~~~~~~G~~~a~~~~ia~~--~~~~~~~~~~~ 80 (416)
T PRK15099 3 LAKASLWTAASTLVKIGAGLLVVKLLAVSFGPAGVGQAGNFRQLITVLGVLAGAGIFNGVTKYVAQY--HDQPQQLRAVV 80 (416)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCcHHHHHHHHHHHHHHHHHHHHcCCccceeeeeHHhc--CCCHHHHHHHH
Confidence 5677788889999999999999999999 79999999999999888455555888888888889988 67888999999
Q ss_pred HHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHH
Q 013357 130 QRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATL 208 (444)
Q Consensus 130 ~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~ 208 (444)
++++.+....++++. +++.+.+|+...+..+++. ..++.+..+..+...+.....+.+|+.||++.++..++++.
T Consensus 81 ~~~~~l~~~~~~i~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lr~~~~~~~~~~~~~~~~ 156 (416)
T PRK15099 81 GTSSAMVLGFSTLLALVFLLAAAPISQGLFGHTDY----QGVVRAVALIQMGIAWANLLLAILKGFRDAAGNALSLIVGS 156 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChhH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999998887 5677888988877776653 23566666666677888899999999999999999999999
Q ss_pred HHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHHHHHHHHH
Q 013357 209 VLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETW 288 (444)
Q Consensus 209 i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~ 288 (444)
++|+.+ +++.... .|+.|+++|+.+++.+..+...++++|+++.+.+..+++.+ ++.+|+++++|.|..+++....+
T Consensus 157 ~~~i~l-~i~~~~~-~Gv~Ga~iat~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~k~ll~~g~p~~~~~~~~~i 233 (416)
T PRK15099 157 LIGVAA-YYLCYRL-GGYEGALLGLALVPALVVLPAGIMLIRRGTIPLSYLKPSWD-NGLAGQLGKFTLMALITSVTLPV 233 (416)
T ss_pred HHHHHH-HHHHHHH-hcchHHHHHHHHHHHHHHHHHHHHHHHccceehHhhhccCC-HHHHHHHHHHHHHHHHHHHHHHH
Confidence 999887 4444432 49999999999999998887777776553322221122222 35689999999999999999999
Q ss_pred HHHHHHHHHh-hcCchHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHH
Q 013357 289 YFQILVLIAG-LLDNPELALDSLSVCMAVSG-LLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFA 366 (444)
Q Consensus 289 ~~~~~~~~~~-~~g~~~~~va~~~~~~~i~~-~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (444)
....++.+++ .+|+ .++|.|+++.|+.+ +...+..+++++..|.++++ +|+++.++..++..+....++++.+
T Consensus 234 ~~~~~~~~l~~~~g~--~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (416)
T PRK15099 234 AYVMMRNLLAAHYSW--DEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL---TEKRDITREIVKALKFVLPAVAAAS 308 (416)
T ss_pred HHHHHHHHHHhcCCH--HHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CChHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999998886 7774 46779999999977 45889999999999999995 6789999999999999999999999
Q ss_pred HHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhhH
Q 013357 367 VIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIHL 435 (444)
Q Consensus 367 ~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~ 435 (444)
++++++++++.+++.+|+ .+.+.+++++++++.++...+..+...+-+.++.+...........+++
T Consensus 309 ~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~l~i 375 (416)
T PRK15099 309 FTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLKVGAYVFGYLVIAKASLRFYILAEVSQFTLLT 375 (416)
T ss_pred HHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999998754 4446778888888888887777766666666666555555555554444
No 12
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.96 E-value=1.1e-24 Score=213.41 Aligned_cols=355 Identities=14% Similarity=0.101 Sum_probs=303.1
Q ss_pred cChh-HHHHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHH
Q 013357 79 LGNL-ELAAASLGNSGIQLFAYGLM-LGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLI 155 (444)
Q Consensus 79 lg~~-~~a~~~~a~~~~~~~~~~~~-~gl~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~ 155 (444)
+|.. +..+|.++.++...+...+. .++.++..|..++.. ++|+|+.++..+....+..+..+.+. +.+.++++++.
T Consensus 5 fG~s~~~Daf~~A~~ip~~l~~l~~~gal~~~~IP~~~~~~-~~~~~~~~~f~~~~~~~~~~~~~~l~~l~~lfa~~iv~ 83 (451)
T PF03023_consen 5 FGASAEADAFFVAFTIPNFLRSLLAGGALSAAFIPVFSKAR-EKGEEEARRFISTLLTILLIISLLLTLLGILFAPPIVR 83 (451)
T ss_pred hcCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5644 57799999999994443444 468999999999999 88999999999998888887777777 45788899988
Q ss_pred Hc--CCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHHhcCCc---cchhH
Q 013357 156 LL--GESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAG---LIGAS 230 (444)
Q Consensus 156 ~~--~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~~i~l~~ili~~~~~g---~~g~~ 230 (444)
++ +.+++..+.+.+.+++..+..++..+..+..+++++++|...+....++.++..++..+++... .| +.+.+
T Consensus 84 ~la~g~~~~~~~la~~l~~i~~~~~~~~~l~~i~~a~L~~~~~F~~~~~~~l~~N~~~I~~~~~~~~~--~~~~~i~~la 161 (451)
T PF03023_consen 84 LLAPGFSPETIELAVQLLRILAPSILFIGLSSIFSAILNAHRRFLIPALSPLLFNLSIILSLLLLSNS--WGQENIYALA 161 (451)
T ss_pred HHCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcchHHHHHHHHHHHHHHHHHHHHHHh--cCchHHHHHH
Confidence 87 5577888999999999999999999999999999999999999999998887766654444333 56 88999
Q ss_pred HHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhhcCchHHHHHHH
Q 013357 231 LVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYFQILVLIAGLLDNPELALDSL 310 (444)
Q Consensus 231 ~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~va~~ 310 (444)
+|..++.++..++.+...+|.+ .+.+ ..++.++ +..|++++...|..+.....++...+++.+.+.++++.. +++
T Consensus 162 ~g~~~g~~~~~l~~l~~~~~~~-~~~~-~~~~~~~-~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~v--s~l 236 (451)
T PF03023_consen 162 WGVLIGAIIQFLIQLPYLRRFG-FRFR-PKFDWRD-PNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGSV--SAL 236 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC-Cccc-ccCCCCC-hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccHH--HHH
Confidence 9999999999999888887763 2211 1222222 458999999999999999999999999999999997665 499
Q ss_pred HHHHHHHHHHHH-HHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhcc----CcHH
Q 013357 311 SVCMAVSGLLFM-VSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFT----SGEV 385 (444)
Q Consensus 311 ~~~~~i~~~~~~-~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~----~~~~ 385 (444)
+.+.++.+++.. +..+++++..|.+++...++|.++.++..+++++....+.+|.++.+..+++++.+++. -|+|
T Consensus 237 ~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~~~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~ 316 (451)
T PF03023_consen 237 NYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWEEFRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAE 316 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHH
Confidence 999999999885 57799999999999999999999999999999999999999999999999999999964 2677
Q ss_pred HHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhhHHHHHhh
Q 013357 386 VANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIHLLCYNQL 441 (444)
Q Consensus 386 ~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~ 441 (444)
..+.....+++++++.++.+++.++...+.+.||++.+........++++.....+
T Consensus 317 ~~~~ta~~l~~y~~~l~~~~l~~ll~r~fya~~~~~~~~~~~~~~~~lni~l~~~l 372 (451)
T PF03023_consen 317 DTQLTASALRIYALGLPFYALNDLLSRVFYALGDTKTPVRISVISVVLNIILSILL 372 (451)
T ss_pred HHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHccCcHhHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999999999888888888887665444
No 13
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.95 E-value=3.3e-23 Score=199.76 Aligned_cols=387 Identities=13% Similarity=0.066 Sum_probs=318.1
Q ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChh-HHHHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhcCCCcc
Q 013357 47 ELKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNL-ELAAASLGNSGIQLFAYGLM-LGMGSAVETLCGQAYGAGRYE 123 (444)
Q Consensus 47 ~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~-~~a~~~~a~~~~~~~~~~~~-~gl~~~~~~~~s~~~g~~~~~ 123 (444)
.-++++|.+.-.....+++.+.+++...+++. +|.. ...++.++.++.+.+--.+. .+++++..|...++..+++.|
T Consensus 5 ~~~sllks~~~vs~~Tl~SRi~G~vRd~~iA~~fGa~~~aDAF~vAf~iPN~lRrlfaegafs~aFVPv~~~~~~~~~~~ 84 (518)
T COG0728 5 SKMSLLKSLIIVSSATLLSRILGFVRDVLIAAAFGAGAAADAFFVAFKLPNLLRRLFAEGAFSSAFVPVLAEAKKKEGEE 84 (518)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCchHHHHHHHHHHhHHHHHHHHhchhHhhhhhHHHHHHHHcchhh
Confidence 34567777888888999999999998888888 7874 67799999999994444443 445899999999999888777
Q ss_pred hHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHc-CC--CHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchH
Q 013357 124 MLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILL-GE--STAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLP 199 (444)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~-~~--~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~ 199 (444)
+.++..+........+.+... +...+.+.+.... .. +++....+....++..+..++.++.....+.+++.+|...
T Consensus 85 ~~~~f~~~v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~~~~~~~~a~~l~~i~~Pyl~~isL~al~~aiLNs~~~F~~ 164 (518)
T COG0728 85 AARFFSRLVTGLLTLVLLLVTLLGILFAPWLVRLLLAPGFDETDKFLAVLLTRILFPYLLFISLSALFGAILNSRNRFFI 164 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeech
Confidence 777777777655555555555 4566777777344 33 2344446788889999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHH
Q 013357 200 SAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSS 279 (444)
Q Consensus 200 ~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~ 279 (444)
+....++.++.-+.....+.+.......+.+++..++.+.+.++.+..++|.+...+. ++.+++ +..|++.+...|.
T Consensus 165 ~a~aPvl~Nv~~I~~~l~~~~~~~~~~~~La~gvl~Gg~~Q~l~~lp~l~~~g~~~~p--~~~~~~-~~lk~~~~~~~p~ 241 (518)
T COG0728 165 PAFAPVLLNVSVIGLALFLGPYFDPPLLALAWGVLIGGLLQLLVQLPALRKAGLLIKP--RFGFKD-PGLKRFLKLMLPA 241 (518)
T ss_pred hhhhHHHHHHHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHcccccCC--CCCCCc-hhHHHHHHHHHHH
Confidence 9999999988877666655555322477889999999999999999999887422221 222332 4599999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHH
Q 013357 280 AVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLF-MVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSIS 358 (444)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~-~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 358 (444)
.+.....++...+++.+.+.+.++..+ .++.++++.+++. .+..++++++.|.++++..++|.++.++..+++++.+
T Consensus 242 ~l~~sisQi~lli~~~iAS~l~~Gsis--~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~~~~~~~l~~~i~l~ 319 (518)
T COG0728 242 LLGVSISQINLLIDTAIASFLAEGSVS--WLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDWPEFLKLLDWGLRLT 319 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHhhccccHH--HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCChHHHHHHHHHHHHHH
Confidence 999999999999999999999866655 9999999999998 5688999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhhhhccC----cHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhh
Q 013357 359 FIISVVFAVIVLALRHVISYAFTS----GEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIH 434 (444)
Q Consensus 359 ~~~~~~~~~~~~~~~~~l~~l~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~ 434 (444)
+.+++|.++++.++++|+.+.+.. ++++.....+.+..++++.+...+..++...+++.+|++.++.......+.+
T Consensus 320 lll~lP~~~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll~~~FYAr~d~ktP~~i~ii~~~~n 399 (518)
T COG0728 320 LLLTLPASAGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLLSRVFYAREDTKTPMKIAIISLVVN 399 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHccCCCcChHHHHHHHHHH
Confidence 999999999999999999999632 5677888999999999999999999999999999999888766666666665
Q ss_pred HHHH
Q 013357 435 LLCY 438 (444)
Q Consensus 435 ~~~~ 438 (444)
...-
T Consensus 400 ~~l~ 403 (518)
T COG0728 400 ILLN 403 (518)
T ss_pred HHHH
Confidence 5443
No 14
>PRK10459 colanic acid exporter; Provisional
Probab=99.93 E-value=8e-22 Score=197.24 Aligned_cols=360 Identities=11% Similarity=0.052 Sum_probs=278.5
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHH
Q 013357 49 KLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGV 127 (444)
Q Consensus 49 ~~il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~ 127 (444)
++..+-+....+++....+.+++...+++| +|++++|.++.+..+..+.......|++++.. |. +|. .++
T Consensus 5 ~~~~~g~~w~~~~~~~~~~~~~i~~~ilaR~L~p~~~G~~~~~~~~~~~~~~~~~~Gl~~aii----~~---~~~--~~~ 75 (492)
T PRK10459 5 EKTISGAKWTAISTVIIIGLQLVQLTVLARILDNHQFGLLTMSLVIIGFADTLSDMGIGASII----QR---QDI--SHL 75 (492)
T ss_pred HHHHccccHHHHHHHHHHHHHHHHHHHHHHhCCHHHccHHHHHHHHHHHHHHHHHcCHHHHHH----hc---ccC--CHH
Confidence 567788888999999999999999999999 79999999999999999556667778877642 21 121 123
Q ss_pred HHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHH
Q 013357 128 YMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAA 206 (444)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~ 206 (444)
.....+.+....+++..++ +.+.+++...+ ++++. ...+++..+..++..+.....+.++..+|.+.....+..
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~r~~~f~~~a~~~~~ 150 (492)
T PRK10459 76 QLSTLYWLNVGLGIVVFVLVFLLSPLIADFY-HNPEL----APLIKTLSLAFVIIPIGQQFRALLQKELEFNKLAKIEIS 150 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHc-CChhh----HHHHHHHHHHHHHHHHhhHHHHHHHHHhhhHHHHHHHHH
Confidence 4455566666666666544 44444444444 34443 346777788888888888899999999999999999988
Q ss_pred HHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHHHHHHH
Q 013357 207 TLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLE 286 (444)
Q Consensus 207 ~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~ 286 (444)
..++..++.+.+... ++|..+..++..++..+..+...+..+++ .++++ +++ ++..|++++++.|...++...
T Consensus 151 ~~i~~~~~~i~~~~~-~~g~~~l~~~~~~~~~~~~l~~~~~~~~~--~~~~~-~~~---~~~~k~ll~~~~~~~~~~~~~ 223 (492)
T PRK10459 151 AVVAGFTFAVVSAFF-WPGALAAILGYLVNSSVRTLLFGYFGRKI--YRPAL-HFS---LASVKPNLSFGAWQTAERIIN 223 (492)
T ss_pred HHHHHHHHHHHHHHH-CCcHHHHHHHHHHHHHHHHHHHHHHhccc--CCccc-eec---HHHHHHHHhhhHHHHHHHHHH
Confidence 888877777666554 68999999999999888776554333322 11111 122 345899999999999999999
Q ss_pred HHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHH
Q 013357 287 TWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFM-VSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVF 365 (444)
Q Consensus 287 ~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~-~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (444)
.+...+|+.+++.+.+ ..++|.|+.+.++.+++.. +...++++..|..++. ++|.++.++..++.+++...+++|.
T Consensus 224 ~~~~~~d~~~lg~~lg-~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~~~~~~~~~~~~~~~~~~~~p~ 300 (492)
T PRK10459 224 YLNTNIDTILIGRILG-AEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDTEKLRVGFLKLLSVLGIINFPL 300 (492)
T ss_pred HHHhcCchhhhhHhhc-hHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999888754 3447899999999887654 4556788999999885 5788999999999999999999999
Q ss_pred HHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhh
Q 013357 366 AVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIH 434 (444)
Q Consensus 366 ~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~ 434 (444)
.+++.++++++..++.+|+ .+.+...++++++..++..+..+....+++.|+++...........+.
T Consensus 301 ~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~~~~~~~~~~~ 367 (492)
T PRK10459 301 LLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSFKWNVFKTFLF 367 (492)
T ss_pred HHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhHHHHHHHHHHH
Confidence 9999999999999886643 566889999999999999999999999999998887654444443333
No 15
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.91 E-value=7.9e-21 Score=189.62 Aligned_cols=377 Identities=16% Similarity=0.136 Sum_probs=289.0
Q ss_pred HHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcch
Q 013357 46 LELKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEM 124 (444)
Q Consensus 46 ~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~ 124 (444)
+..++..|.+.....+++...+..++....++| +|++++|.++.+..+..++......|+..+....++++.+++++..
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lar~lg~~~~G~~~~~~~~~~~~~~i~~~G~~~ai~r~ia~~~~~~~~~~ 82 (480)
T COG2244 3 SLKKKLIKGALWLLLGTLISALLGLITIPLLARLLGPEGFGLYALALAIIGLFSILADFGLPAAITREIAEYREKGEYLL 82 (480)
T ss_pred hHHHHHHhhchHHHHHHHHHHHHHHHHHHHHHHHhCcccceeeehHHHHHHHHHHHHHcCCcHHHHHHHHHhhcccHHHH
Confidence 356788888999999999999999999999999 7999999999999999966666679999999999998876666555
Q ss_pred HHHH-HHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHH
Q 013357 125 LGVY-MQRATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYI 203 (444)
Q Consensus 125 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 203 (444)
.... ...........+++.........+. +++ ....+.+..+..++........+.+|+.++.+.....
T Consensus 83 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (480)
T COG2244 83 LILLSVLLLLLLALILLLLLLLIAYLLAPI------DPV----LALLLRILSLALLLLPLSSVLRGLFQGFGRFGPLALS 152 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhccc------Chh----hHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccchhH
Confidence 5554 4444444444443333322222222 222 2335778899999999999999999999999999998
Q ss_pred HHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHHHH
Q 013357 204 SAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVML 283 (444)
Q Consensus 204 ~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~ 283 (444)
.+.. ..-+...+.+.. .......++...+..........+..++++... ...++. .++.+|+.++.++|..+..
T Consensus 153 ~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~l~~~~p~~~~~ 226 (480)
T COG2244 153 IVSS-IFLLAAVFALLF---AALGLAVWALVLGAVVSLLVLLILLGKKKRGLK-RPILRF-SLALLKELLRFGLPLLLSS 226 (480)
T ss_pred HHHH-HHHHHHHHHHHH---HhhhHHHHHHHHHHHHHHHHHHHHHHHhhhhcc-ccccCc-hhHHHHHHHHHhhHHHHHH
Confidence 4444 111222222221 245556666666666655555555542211111 111221 2466999999999999999
Q ss_pred HHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH
Q 013357 284 CLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISV 363 (444)
Q Consensus 284 ~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 363 (444)
....+..+.|+++++.+-+ +..+|.|+.+.++......+..+++.+..|.+++...++|.++.++..++++++...+++
T Consensus 227 ~~~~l~~~~D~~~i~~~l~-~~~vG~Y~~a~~i~~~~~~~~~~l~~~l~P~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (480)
T COG2244 227 LLNFLFTNIDTLLLGLFLG-PAQVGIYSAAQRLVSLLLIVASALNRVLFPALSRAYAEGDRKALKKLLRQSLKLLLLISI 305 (480)
T ss_pred HHHHHHHHHHHHHHHHHhh-hhHheecccccHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999988754 344679999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhhHHHHHhh
Q 013357 364 VFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIHLLCYNQL 441 (444)
Q Consensus 364 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~ 441 (444)
|..+++.++++++..++.+++ ...+...++++++..++.+........+++.|+++............+++.-+++
T Consensus 306 p~~~~l~~~~~~~i~~~fg~~--~~~~~~~l~il~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~~~~l~~~l 381 (480)
T COG2244 306 PALLGLLLLAPPIITLLFGEK--YASAAPILQLLALAGLFLSLVSLTSSLLQALGKQRLLLLISLISALLNLILNLLL 381 (480)
T ss_pred HHHHHHHHHHhhhheeecCCc--ccchhHHHHHHHHHHHHHHHHHHHHHHHHHcCcchhhHHHHHHHHHHHHHHHhHH
Confidence 999999999999999976654 2337889999999999999999999999999999988777777766666544443
No 16
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=99.90 E-value=4.7e-22 Score=196.45 Aligned_cols=209 Identities=18% Similarity=0.140 Sum_probs=193.1
Q ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCC
Q 013357 42 IASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGR 121 (444)
Q Consensus 42 ~~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~ 121 (444)
+.+.+..|++++.++|.+++++.......+|..+++++|++++++++++.++.. +...+..|++++.+++++|++|+||
T Consensus 229 ~~~~~~~k~il~lg~P~~~~~~~~~~~~~i~~~~i~~~G~~alAa~~i~~~i~~-l~~~~~~gi~~a~~~lvgq~~Ga~~ 307 (464)
T PRK00187 229 RPSRAALRELWRLGLPIGGTYAVEVGLFTFAALCMGALGSTQLAAHQIALQIVS-VAFMVPVGLSYAVTMRVGQHYGAGR 307 (464)
T ss_pred CCCHHHHHHHHHhhhhHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 446678999999999999999999999999999999999999999999999999 8999999999999999999999999
Q ss_pred cchHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCC--CH---HHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcC
Q 013357 122 YEMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGE--ST---AVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQS 195 (444)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~--~~---~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g 195 (444)
+|++++..+.++.++.+.+++.. +++.+.+++.+.+.. ++ |+.+.+..|+++..++.++..++.+..+.+||.|
T Consensus 308 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~~lrg~G 387 (464)
T PRK00187 308 LLEARRAGRVGIGFGAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMGAIRGLK 387 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHHhHhccC
Confidence 99999999999999999998887 557789999988853 43 7889999999999999999999999999999999
Q ss_pred CchHHHHHHHHHH-HHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 196 IVLPSAYISAATL-VLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 196 ~~~~~~~~~~~~~-i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
|++.++..++++. ++++++++++.+.+++|+.|+|+++.+++.+..+.....++++
T Consensus 388 ~~~~~~~~~~~~~~~~~ipl~~ll~~~~~~g~~Gvw~~~~i~~~~~~~~~~~~~~~~ 444 (464)
T PRK00187 388 DARTTFLIGLACYWLVGAPLAWLLAFTLGWGAVGVWWGLALGLACAAVALTLAFEWK 444 (464)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHHhccCCCceeeHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999985 9999999999998889999999999999999988877666543
No 17
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=99.89 E-value=3.3e-21 Score=188.84 Aligned_cols=213 Identities=22% Similarity=0.245 Sum_probs=200.7
Q ss_pred hhhHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhc
Q 013357 39 RLQIASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYG 118 (444)
Q Consensus 39 ~~~~~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g 118 (444)
+..+++++..|++++.+.|.+++++.......+.+.+++++|++.+|+++++.++.+ +...+..|++++.++++++++|
T Consensus 231 ~~~~~~~~~~~~i~~lG~p~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~-~~~~~~~gi~~a~~~lvG~~~G 309 (455)
T COG0534 231 KLLKPDRKLLKEILRLGLPIFLESLSESLGFLLLTLFVARLGTVALAAYGIALRIAS-FIFMPPFGIAQAVTILVGQNLG 309 (455)
T ss_pred hccCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHHHHHHhcChHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhC
Confidence 344677899999999999999999999999999999999999999999999999999 9999999999999999999999
Q ss_pred CCCcchHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCc
Q 013357 119 AGRYEMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIV 197 (444)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~ 197 (444)
+||+|++++..+.+..++..+++... +.+.+.+++..+|..|+|+.+.+..++++..+..++.+.+.+..+.+||.||+
T Consensus 310 a~~~~~a~~~~~~~~~~~~~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g~lrg~g~~ 389 (455)
T COG0534 310 AGNYKRARRAARLALKLSLLIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSGVLRGAGDA 389 (455)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCc
Confidence 99999999999999999999998887 56889999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHH-HHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhccc
Q 013357 198 LPSAYISAAT-LVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDK 253 (444)
Q Consensus 198 ~~~~~~~~~~-~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~ 253 (444)
+.++..++++ ..+.+++.+++.+.+ +|..|+|++...++.+..+...++++++++
T Consensus 390 ~~~~~~~~~~~~~~~lp~~~~l~~~~-~g~~Gvw~~~~~~~~~~~~~~~~~~~~~~~ 445 (455)
T COG0534 390 KIPFIISLLSYWGFRLPLAYLLGFFF-LGLAGVWIGFPLSLILRAILLLLRLRRGRW 445 (455)
T ss_pred HHHHHHHHHHHHHHHHhHHHHHhhhc-ccchHHHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 9999999998 677889988888765 899999999999999999999998887633
No 18
>PRK10189 MATE family multidrug exporter; Provisional
Probab=99.89 E-value=6.1e-21 Score=188.65 Aligned_cols=212 Identities=12% Similarity=0.120 Sum_probs=196.7
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 43 ~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
.+.+.+|++++.++|.+++.....+...+.+.+++++|++++|+++++.++.+ +...+..|++++.++++++++|+||.
T Consensus 253 ~~~~~~~~il~iG~P~~~~~~~~~~~~~~~~~~~~~~G~~~~Aa~~I~~~i~~-~~~~~~~gi~~A~~~lvg~~~Ga~~~ 331 (478)
T PRK10189 253 LNFAIIWEVMGIGIPASIESVLFNGGKLLTQMFVAGMGTSVIAGNFIAFSIAA-LINLPGNALGSASTIITGTRLGKGQI 331 (478)
T ss_pred CCHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhCCCCH
Confidence 45678999999999999999999999999899999999999999999999999 88889999999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHH
Q 013357 123 EMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 201 (444)
+++++..+.+..++.+.++... +++.+.+++..+|..|+|+.+.+..++++.++..++.+.+.+..+.+||.||++.++
T Consensus 332 ~~a~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g~lrg~G~t~~~~ 411 (478)
T PRK10189 332 AQAERQLRHVFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPAGLKGARDARYAM 411 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHhhcCCCchHHH
Confidence 9999999999999999988887 557799999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHH-HHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhccccc
Q 013357 202 YISAAT-LVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCK 255 (444)
Q Consensus 202 ~~~~~~-~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~ 255 (444)
..++.+ .++.+++.+++....++|+.|+|++..+++.+..++.++++++.+|.+
T Consensus 412 ~i~~~~~~~v~ip~~~ll~~~~~~g~~Gvw~~~~~~~~~~~~~~~~r~~~~~W~~ 466 (478)
T PRK10189 412 WVSMLGMWGCRVVAGYILGIMLGFGVVGVWMGMFLDWAVRGVLFYWRMVSGRWLW 466 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 999998 588889998887777899999999999999999999888887765544
No 19
>PRK01766 multidrug efflux protein; Reviewed
Probab=99.89 E-value=5.2e-21 Score=189.38 Aligned_cols=208 Identities=17% Similarity=0.163 Sum_probs=194.7
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 43 ~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
.+++..|++++.++|.+++.........++..+++++|++++++++++.++.+ +...+..|++++.++.++|++|+||+
T Consensus 233 ~~~~~~k~il~l~~P~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~-~~~~~~~gl~~a~~~~v~~~~Ga~~~ 311 (456)
T PRK01766 233 PDWAVIKRLLKLGLPIGLAIFFEVSLFAVVTLLVSPLGTVTVAAHQIALNFSS-LLFMLPLSLAMALTIRVGFELGAGRT 311 (456)
T ss_pred CCHHHHHHHHHccchHHHHHHHHHHHHHHHHHHHHHcChHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCCH
Confidence 45667999999999999999999999999999999999999999999999999 77888999999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHH
Q 013357 123 EMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 201 (444)
+++++..+.++.++...+++.. +++.+.+++..++..|+|+.+.+..|+++..+..++..+.....+.+||.||++.++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~~l~g~g~~~~~~ 391 (456)
T PRK01766 312 LDARQYAYIGLAVGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSGALRGYKDTRVIF 391 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhchhccCccHHHH
Confidence 9999999999999999998887 567799999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHH-HHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 202 YISAATL-VLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 202 ~~~~~~~-i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
..++++. ++++++.+++.+..++|+.|+|+++.+++++..++.++++++.
T Consensus 392 ~~~~~~~~~~~i~~~~~l~~~~~~G~~G~~~~~~~~~~~~~~~~~~~~~~~ 442 (456)
T PRK01766 392 FITFIAYWVLGLPLGYILALTDPMGPFGFWIGLIIGLTAAAILLLLRLRKL 442 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCCceehHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999985 7899999998887789999999999999999999888877654
No 20
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=99.87 E-value=3.2e-20 Score=183.08 Aligned_cols=207 Identities=14% Similarity=0.215 Sum_probs=190.0
Q ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccCh-hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCC
Q 013357 42 IASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGN-LELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAG 120 (444)
Q Consensus 42 ~~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~-~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~ 120 (444)
+.+++..|++++.+.|..++.....+...+.+.+++++|+ +++|+++++.++.. +...+..|++++.++.++|++|+|
T Consensus 227 ~~~~~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~g~~~~lAa~~i~~~i~~-~~~~~~~gi~~a~~~lvg~~~Ga~ 305 (453)
T PRK09575 227 RFNWSLAPKIVLLGSSSFFMYLYGSFVVALHNRLFMEYGSALTVGAYAIVGYLMV-LYYLVAEGIAEGMQPPVSYYFGAR 305 (453)
T ss_pred CcCHHHHHHHHHhChhHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHHHHHHH-HHHHHHHHHHHhhHHHHHHHhcCC
Confidence 4567789999999999999999999999999999999985 68999999999999 889999999999999999999999
Q ss_pred CcchHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCC-CHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCch
Q 013357 121 RYEMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGE-STAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVL 198 (444)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~ 198 (444)
|+|++++..+.++.++...+++.. +++.+.+++..+++. |+|+.+.+.+|+++..++.++..+..+..+++||.||++
T Consensus 306 ~~~~~~~~~~~~l~l~~~~~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~~~g~~~ 385 (453)
T PRK09575 306 QYDNIKKLLKLAMKVTVLAGIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLASAYFMAVNQGG 385 (453)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcH
Confidence 999999999999999999999988 557799999999985 789999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 199 PSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 199 ~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
.++..+....++++++.+++... +|+.|+|+++.+++.+..+...+.++++
T Consensus 386 ~~~~~~~~~~~v~ip~~~ll~~~--~G~~Gvw~a~~~~~~~~~~~~~~~~~~~ 436 (453)
T PRK09575 386 KALFISIGNMLIQLPFLFILPKW--LGVDGVWLAMPLSNIALSLVVAPMLWRD 436 (453)
T ss_pred HHHHHHHHhHHHHHHHHHHHHHH--HCcchHhhHHHHHHHHHHHHHHHHHHHH
Confidence 99999998888899888887654 6999999999999999888887777654
No 21
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.84 E-value=2.7e-18 Score=172.43 Aligned_cols=206 Identities=17% Similarity=0.149 Sum_probs=185.9
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 013357 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (444)
Q Consensus 44 ~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~ 123 (444)
+++..|++++.+.|..++++...+...+|+.+.+.+|++++++|+.+.++.......+..+++++..|.+++++++||++
T Consensus 218 ~~~~~k~~l~~~~p~~~~~~~~~~~~~id~~~~~~~~~~~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~ 297 (502)
T TIGR01695 218 RDPGLKRFLKLFLPTTLGSSASQITLLINTALASFLEIGSVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWN 297 (502)
T ss_pred CChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHH
Confidence 45678999999999999999999999999988666899999999999999883334467899999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCC----CHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCch
Q 013357 124 MLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGE----STAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVL 198 (444)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~ 198 (444)
+.++..+++......++++.. ++..++++++.++.. ++|..+.+..++++++++.++..+.....+.+++.||++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~ 377 (502)
T TIGR01695 298 ELRDLLNQGIRLSLLLTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTR 377 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCc
Confidence 999999999999999999988 467799999988765 567788899999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 199 PSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 199 ~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
.+++.+....++|+++++++++. +|..|+++|+.+++.+..++..++.+|+
T Consensus 378 ~~~~~~~~~~~i~i~l~~~l~~~--~G~~G~~~a~~i~~~~~~~~~~~~~~~~ 428 (502)
T TIGR01695 378 TPFINSVISVVLNALLSLLLIFP--LGLVGIALATSAASMVSSVLLYLMLNRR 428 (502)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHH--HhhhHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999875 6999999999999999999888777765
No 22
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=99.79 E-value=6.8e-17 Score=158.37 Aligned_cols=199 Identities=17% Similarity=0.082 Sum_probs=171.0
Q ss_pred HHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchH
Q 013357 46 LELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEML 125 (444)
Q Consensus 46 ~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~ 125 (444)
+..|++++.+.|..+++........+.+.+++++|++++|+++++.++.+ +...+..|++++.+++++|++|+||+|++
T Consensus 229 ~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~G~~alAa~~I~~~i~~-~~~~~~~gl~~a~~~lvg~~~Ga~~~~~a 307 (441)
T PRK10367 229 GNFRRLLALNRDIMLRSLLLQLCFGAITVLGARLGSDIIAVNAVLMTLLT-FTAYALDGFAYAVEAHSGQAYGARDGSQL 307 (441)
T ss_pred HHHHHHHHhCchHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHH-HHHHHHHhHHHHHHHHHHHHHcCCCHHHH
Confidence 46899999999999999999999999999999999999999999999999 89999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCC---chHHH
Q 013357 126 GVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSI---VLPSA 201 (444)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~---~~~~~ 201 (444)
++..+.+..++.+.+.+.. +++.+.+++..+|.+|+|+.+.+..++++..+..+.........+.++|.+| ++.++
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~g~lrg~dt~~~~ 387 (441)
T PRK10367 308 LDVWRAACRQSGIVALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVILPLVGVWCYLLDGMFIGATRAAEMRNSM 387 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCccchHHHHHHH
Confidence 9999999999999998888 4577899999999999999999999999988764433345555555666665 88888
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 202 YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 202 ~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
..+.++..+ ..+... ++|..|+|++..+++.+..+...++++++
T Consensus 388 ~~~~~~~~~----~~~~~~--~~g~~Gvw~a~~~~~~~~~i~~~~~~~~~ 431 (441)
T PRK10367 388 AVAAAGFAL----TLLTLP--WLGNHGLWLALTVFLALRGLSLAAIWRRH 431 (441)
T ss_pred HHHHHHHHH----HHHHHH--HcCchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 888887432 112222 37999999999999999999988777654
No 23
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.77 E-value=8.5e-16 Score=150.87 Aligned_cols=207 Identities=20% Similarity=0.182 Sum_probs=191.5
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 43 ~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
.+++..|++++...|..++....++...+|+.+.+.+++.++++++.+.++.++....+..++++...|..++...+||.
T Consensus 192 ~~~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~vs~l~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~ 271 (451)
T PF03023_consen 192 WRDPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGSVSALNYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDW 271 (451)
T ss_pred CCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCH
Confidence 34567999999999999999999999999999999999999999999999999666677889999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcC----CCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCc
Q 013357 123 EMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLG----ESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIV 197 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~----~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~ 197 (444)
++.++..++++.....+.++.+ .++.+++|++.++. .++|..+.....+.+++++.++.++...+...+.+.+|+
T Consensus 272 ~~~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~~~~~ta~~l~~y~~~l~~~~l~~ll~r~fya~~~~ 351 (451)
T PF03023_consen 272 EEFRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAEDTQLTASALRIYALGLPFYALNDLLSRVFYALGDT 351 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHccCc
Confidence 9999999999999999999998 56789999997774 366778888999999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 198 LPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 198 ~~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
|.+++.++++.++|++++.++... +|..|.++|+.++..+..+..++.++|+
T Consensus 352 ~~~~~~~~~~~~lni~l~~~l~~~--~g~~Glala~sl~~~i~~~~l~~~l~r~ 403 (451)
T PF03023_consen 352 KTPVRISVISVVLNIILSILLVPF--FGVAGLALATSLSAIISALLLYILLRRR 403 (451)
T ss_pred HhHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999888876 7999999999999999999998888776
No 24
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=99.76 E-value=5.9e-15 Score=135.81 Aligned_cols=270 Identities=19% Similarity=0.203 Sum_probs=203.8
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHH
Q 013357 52 VRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQ 130 (444)
Q Consensus 52 l~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~~~~ 130 (444)
+|.+.....+++...+.+++...++.| +|++++|.++....+..++......|++++.....++...+ +++.+....
T Consensus 2 ~k~~~~~~~~~~~~~~~~~~~~~il~r~l~~~~~G~~~~~~~~~~~~~~~~~~G~~~~~~r~~~~~~~~--~~~~~~~~~ 79 (273)
T PF01943_consen 2 LKNSLWLFLSNILSALIGFITIPILARYLGPEEYGIYSLALSIVSLLSILADLGLSQAIVRFIAEYKDK--KELRSAYFS 79 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHhhhh--HHHHHHHHH
Confidence 567778889999999999999999999 79999999999999999555556899999988888876543 344455555
Q ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHH
Q 013357 131 RATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVL 210 (444)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~ 210 (444)
.......+.+++..+..... ..+..+ +... .+........+.........+++++.++.+.....++...+.
T Consensus 80 ~~~~~~~~~~~i~~~~~~~~----~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (273)
T PF01943_consen 80 SVLFLLLIFSLIFLLILLIA----SFFGNP-SLSL---ILIILALLILILSSLSSVFSGLLQGLQRFKYIAISNIISSLL 151 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHH----HHcCCc-hHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 54444443333333222221 233333 2221 122222222257788888999999999999999999999888
Q ss_pred HHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHHHHHHHHHHH
Q 013357 211 HLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYF 290 (444)
Q Consensus 211 ~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~ 290 (444)
..+...++... +.+..+..++..++..+..++..++.+|+.+ .++...+ ++..|++++.+.|..+..+...+..
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
T PF01943_consen 152 SLLLILLLLFL-GSSLWGFLLGLVISSLVSLIISLFYLRRKLR--PRFSFFS---KKFFKEILRFGLPLFLSSLLSWLYS 225 (273)
T ss_pred HHHHHHHHHHH-hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHc--ccccccc---hHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 88777666665 3568999999999999998888888776532 2222222 4569999999999999999999999
Q ss_pred HHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 013357 291 QILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNE 338 (444)
Q Consensus 291 ~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~ 338 (444)
..|+.+++.+.+. .++|.|+++.++......+..++.++..|.+++.
T Consensus 226 ~~d~~ii~~~~g~-~~vg~Y~~a~~l~~~~~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 226 QIDRLIIGYFLGP-EAVGIYSVAYRLASAISFLLSSISTVLFPRLSRL 272 (273)
T ss_pred HhHHHHHHHhCCH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999998763 3478999999999999999999999999999885
No 25
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.76 E-value=1.9e-16 Score=158.46 Aligned_cols=204 Identities=13% Similarity=0.129 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cCh------hH---HHHH-HHHHHHHHHHHHHHHHHHHHhHHH
Q 013357 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGN------LE---LAAA-SLGNSGIQLFAYGLMLGMGSAVET 111 (444)
Q Consensus 43 ~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~------~~---~a~~-~~a~~~~~~~~~~~~~gl~~~~~~ 111 (444)
.+++.+|++++.+.|.+++++...+...+|+.++++ +++ ++ ++.+ +.+.++.. +...+..+++++..|
T Consensus 219 ~~~~~~k~l~~~~~p~~l~~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~-~~~~~~~~l~~~~~p 297 (488)
T TIGR02900 219 EGKALLFDLFSVSLPLTLSRFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLT-FPAVITSSLSTALVP 297 (488)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHH-hHHHHHHHHHHHHHH
Confidence 446689999999999999999999999999999987 332 22 2222 34556666 556778899999999
Q ss_pred HHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHH
Q 013357 112 LCGQAYGAGRYEMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKF 190 (444)
Q Consensus 112 ~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~ 190 (444)
.++++.|+||+++.++..++...+...++++.. .+..+.++++.++..+++ +.++++++++..++..+.....+.
T Consensus 298 ~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~----~~~~l~i~~~~~~~~~~~~~~~~~ 373 (488)
T TIGR02900 298 DISEAMAKKNYSSIEKRINQAIKISLLLGLITTVILLVIPDELGALFYGRPD----AGNFIRVLAPSFPFLYFSAPLQSI 373 (488)
T ss_pred HHHHHHHcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCc----hHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999887 457788898888875433 567899999999999999999999
Q ss_pred HHHcCCchHHHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 191 LQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 191 l~~~g~~~~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
+++.||++.+++.+++..++|++++++++...++|+.|+++++.+++.+..++..+..+|.
T Consensus 374 l~~~g~~~~~~~~~~~~~i~~i~l~~~l~~~~~~G~~Gaaia~~i~~~~~~~~~~~~~~~~ 434 (488)
T TIGR02900 374 LQGLGKQKVALRNSLIGAIVKIILLFVLTSIPSINIYGYAITFIITSVLVTILNLAEIKKN 434 (488)
T ss_pred HHhcCcchHHHHHHHHHHHHHHHHHHHHHhccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988733347999999999999999999988877654
No 26
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.74 E-value=2.1e-18 Score=145.92 Aligned_cols=160 Identities=24% Similarity=0.394 Sum_probs=153.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHH
Q 013357 57 PAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVL 136 (444)
Q Consensus 57 p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 136 (444)
|.++++++..+...+|+.+++++|++++++++++.++.. +...+..|++++..+.++|++|++|++++++.++++..+.
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~~~~a~~~i~~~~~~-~~~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~~ 79 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGPEALAAYGIASSIFS-ILFMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLLS 79 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTTCCCCHCCHHHHHHH-HHHHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHH-HHhhhcccccccccceeecccccccccccccccccccccc
Confidence 889999999999999999999999999999999999999 8888999999999999999999999999999999999999
Q ss_pred HHHHHHHHH-HHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHH-HHHHHH
Q 013357 137 LATGVPVMM-VYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATL-VLHLLL 214 (444)
Q Consensus 137 ~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~-i~~i~l 214 (444)
..+++++.+ .+.+.+++..+++.|+|+.+.+.+|+++..+..++..+.....+++++.||++..+..+.++. ++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l 159 (162)
T PF01554_consen 80 LIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMYISIISFWIINIPL 159 (162)
T ss_dssp HHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHHHHHHHHHHHHHHH
T ss_pred hhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHHHHHHHHHHHHHhH
Confidence 999999985 478899999999999999999999999999999999999999999999999999999999997 999999
Q ss_pred HHH
Q 013357 215 SWL 217 (444)
Q Consensus 215 ~~i 217 (444)
+|+
T Consensus 160 ~yl 162 (162)
T PF01554_consen 160 AYL 162 (162)
T ss_dssp HHH
T ss_pred HhC
Confidence 875
No 27
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.74 E-value=2.5e-14 Score=138.61 Aligned_cols=208 Identities=15% Similarity=0.134 Sum_probs=190.5
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 43 ~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
.+.+..|++.+...|..++...+++..++|+.+.+.+.+.+.+.+..+.++.++....+..++++...|..|++..++|.
T Consensus 226 ~~~~~lk~~~~~~~p~~l~~sisQi~lli~~~iAS~l~~Gsis~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~ 305 (518)
T COG0728 226 FKDPGLKRFLKLMLPALLGVSISQINLLIDTAIASFLAEGSVSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDW 305 (518)
T ss_pred CCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCCh
Confidence 44478999999999999999999999999999999999999999999999999666789999999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCC----CHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCc
Q 013357 123 EMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGE----STAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIV 197 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~ 197 (444)
++.++..++++++.+++.+|.+ .+..+++|++..+.. +++......+.+..+.++.++..+..++...+.+++|+
T Consensus 306 ~~~~~~l~~~i~l~lll~lP~~~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll~~~FYAr~d~ 385 (518)
T COG0728 306 PEFLKLLDWGLRLTLLLTLPASAGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLLSRVFYAREDT 385 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHccCC
Confidence 9999999999999999999998 567899999977733 45667778889999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhcc
Q 013357 198 LPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSD 252 (444)
Q Consensus 198 ~~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~ 252 (444)
|.|+.+.+++.++|+.+++.+... +|..|.++++.++.++.+.+.++..+|+.
T Consensus 386 ktP~~i~ii~~~~n~~l~~~l~~~--~~~~giala~s~a~~~~~~ll~~~l~k~~ 438 (518)
T COG0728 386 KTPMKIAIISLVVNILLNLLLIPP--LGHVGLALATSLAAWVNALLLYYLLRKRL 438 (518)
T ss_pred CcChHHHHHHHHHHHHHHHHHHhh--ccchHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 999999999999999999777665 68888999999999999999888887763
No 28
>PRK10459 colanic acid exporter; Provisional
Probab=99.73 E-value=2.3e-14 Score=143.46 Aligned_cols=202 Identities=17% Similarity=0.084 Sum_probs=172.3
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 44 ~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
+++..|++++++.|...+++...+...+|+.++++ +|++++|.|+.+.++.......+...+++...|..++. ++|+
T Consensus 202 ~~~~~k~ll~~~~~~~~~~~~~~~~~~~d~~~lg~~lg~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~ 279 (492)
T PRK10459 202 SLASVKPNLSFGAWQTAERIINYLNTNIDTILIGRILGAEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDT 279 (492)
T ss_pred cHHHHHHHHhhhHHHHHHHHHHHHHhcCchhhhhHhhchHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCH
Confidence 45678999999999999999999999999999999 69999999999999988334445555677788988885 5788
Q ss_pred chHHHHHHHHHHHHHHHHHHHHH-HHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHH
Q 013357 123 EMLGVYMQRATFVLLATGVPVMM-VYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 201 (444)
++.++.+++...+...+++++.+ +..++++++.++..++ ...+...++++++...+..+.......+++.||+|...
T Consensus 280 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~ 357 (492)
T PRK10459 280 EKLRVGFLKLLSVLGIINFPLLLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSF 357 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhH
Confidence 89999999999999999999874 5678899887776543 45677899999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 202 YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 202 ~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
..+++..+++++..+++... +|+.|+++++.+++.+......++..|+
T Consensus 358 ~~~~~~~~~~i~~~~~~~~~--~G~~g~a~a~~i~~~~~~~~~~~~~~~~ 405 (492)
T PRK10459 358 KWNVFKTFLFIPAIVIGGQL--AGLIGVALGFLLVQIINTILSYFLMIKP 405 (492)
T ss_pred HHHHHHHHHHHHHHHHHHhh--ccHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99998888888877666654 6999999999999999888888777543
No 29
>PRK15099 O-antigen translocase; Provisional
Probab=99.69 E-value=9.8e-15 Score=142.88 Aligned_cols=203 Identities=9% Similarity=-0.031 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHh-ccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCC
Q 013357 42 IASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCG-HLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAG 120 (444)
Q Consensus 42 ~~~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~-~lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~ 120 (444)
+.+++..|++++.+.|..+++....+....|+.+++ ++|++++|+|+.+.++...+...+..+++++..|.++++ +
T Consensus 208 ~~~~~~~k~ll~~g~p~~~~~~~~~i~~~~~~~~l~~~~g~~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~---~ 284 (416)
T PRK15099 208 SWDNGLAGQLGKFTLMALITSVTLPVAYVMMRNLLAAHYSWDEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL---T 284 (416)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---C
Confidence 446778999999999999999999999999999997 489999999999999988455788999999999999995 5
Q ss_pred CcchHHHHHHHHHHHHHHHHHHHHH-HHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchH
Q 013357 121 RYEMLGVYMQRATFVLLATGVPVMM-VYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLP 199 (444)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~ 199 (444)
|+++.++.+++........+++..+ +++++++++.++..++ .+.+.+++++++++.++..........+.+.++.+.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~~~~~~~g~~~~~~~~~~~ 362 (416)
T PRK15099 285 EKRDITREIVKALKFVLPAVAAASFTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLKVGAYVFGYLVIAKASLRF 362 (416)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 7788899999999988888888774 5689999999887664 333677899988888888887777777778888888
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 200 SAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 200 ~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
.....+...++++++++++++. +|..|+++++.+++.+..++......++
T Consensus 363 ~~~~~~~~~~l~i~l~~~li~~--~G~~G~a~a~~is~~~~~~~~~~~~~~~ 412 (416)
T PRK15099 363 YILAEVSQFTLLTGFAHWLIPL--HGALGAAQAYMATYIVYFSLCCGVFLLY 412 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHH--hhhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 8888888899999999999987 6999999999999999988777666543
No 30
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.65 E-value=9.4e-17 Score=135.72 Aligned_cols=156 Identities=21% Similarity=0.273 Sum_probs=145.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHH
Q 013357 278 SSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSI 357 (444)
Q Consensus 278 p~~~~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~ 357 (444)
|.+++++.+.+.+.++..+++++|+++ +++++++.++..+...+..|++++..+.++|++|++|++++++..++++.+
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~~~--~a~~~i~~~~~~~~~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~ 78 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGPEA--LAAYGIASSIFSILFMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLL 78 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTTCC--CCHCCHHHHHHHHHHHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCHHH--HHHHHHHHHHHHHHhhhcccccccccceeeccccccccccccccccccccc
Confidence 789999999999999999999997654 559999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccc-hhhH
Q 013357 358 SFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNS-KIHL 435 (444)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~-~~~~ 435 (444)
..+++++.++++.++++++.++|++|+|+.+.+.+++++..+..++.+......+.++|.||++...+...... ++++
T Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i 157 (162)
T PF01554_consen 79 SLIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMYISIISFWIINI 157 (162)
T ss_dssp HHHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHHHHHHHHHHHHH
T ss_pred chhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999887766666555 4444
No 31
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=99.60 E-value=6.4e-12 Score=114.13 Aligned_cols=245 Identities=18% Similarity=0.175 Sum_probs=174.8
Q ss_pred HHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHHHH
Q 013357 68 MSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVLLATGVPVMMV 146 (444)
Q Consensus 68 ~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (444)
.+++...+++| +|++++|.++....+..+.......|+.+.... ..++|+++.++..+.......+.+++..++
T Consensus 3 ~~f~~~~~lar~l~~~~~G~~~~~~s~~~~~~~~~~~g~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (251)
T PF13440_consen 3 INFLFLILLARYLGPEDFGIYALIFSIVSILSIVASLGLRQSLVR-----SAARDKQDIRSLLRFSLLVSLLLAVILAIL 77 (251)
T ss_pred HHHHHHHHHHHHCCHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHH-----hhccCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 45667778888 799999999999999994444446676666433 233556666777666665544444333322
Q ss_pred HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHHhcCCcc
Q 013357 147 YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAGL 226 (444)
Q Consensus 147 ~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~~i~l~~ili~~~~~g~ 226 (444)
. ..+...+ .+++. ..++....+..+.........+.+++.+|.+.....+....+........+... +.+.
T Consensus 78 ~---~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 148 (251)
T PF13440_consen 78 A---ILIAYFF-GDPEL----FWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRSLLRLLLLVLLLYL-GLNL 148 (251)
T ss_pred H---HHHHHHh-CChhH----HHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHHH-HhhH
Confidence 1 1111222 33332 235666777788889999999999999999999999999988885555444443 4588
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhh-cCchHH
Q 013357 227 IGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYFQILVLIAGL-LDNPEL 305 (444)
Q Consensus 227 ~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~-~g~~~~ 305 (444)
.+..++..++.++..+......+++ .+.. .+ .+..| .++.+.|..+..+........+..+++. +|. .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--~ 217 (251)
T PF13440_consen 149 WSILLAFIISALLALLISFYLLRRK--LRLS---FK---FSWRR-LLKYGLPFSLSSLLSWLLSQIDRLLIGYFLGP--E 217 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhccc--cCCC---ch---hhHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCH--H
Confidence 8889998888888777665533322 1111 11 12234 7999999999999999999999999999 653 4
Q ss_pred HHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHH
Q 013357 306 ALDSLSVCMAVSGLLF-MVSVGFNAAASVRVSN 337 (444)
Q Consensus 306 ~va~~~~~~~i~~~~~-~~~~~l~~a~~~~i~~ 337 (444)
++|.|+++.++...+. .+..++++...|.++|
T Consensus 218 ~~g~y~~a~~l~~~~~~~~~~~i~~~~~p~lar 250 (251)
T PF13440_consen 218 AVGIYSVAQRLASLPASLLSSAISSVFFPKLAR 250 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhC
Confidence 4679999999999888 9999999999999986
No 32
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.60 E-value=4.7e-13 Score=133.72 Aligned_cols=187 Identities=22% Similarity=0.276 Sum_probs=170.4
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 44 ~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
.++..|+.++.+.|..+++....+.+.+|+.++++ +|++++|.|+.+.++.. ....+...++....|.+++...++|+
T Consensus 208 ~~~~~~~~l~~~~p~~~~~~~~~l~~~~D~~~i~~~l~~~~vG~Y~~a~~i~~-~~~~~~~~l~~~l~P~~s~~~~~~~~ 286 (480)
T COG2244 208 SLALLKELLRFGLPLLLSSLLNFLFTNIDTLLLGLFLGPAQVGIYSAAQRLVS-LLLIVASALNRVLFPALSRAYAEGDR 286 (480)
T ss_pred hhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHhhhhHheecccccHHHH-HHHHHHHHHHHHHHHHHHHHHHcCcH
Confidence 47899999999999999999999999999999999 69999999998888888 88889999999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHHH-HHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHH
Q 013357 123 EMLGVYMQRATFVLLATGVPVMM-VYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 201 (444)
++.++..++...+....+++..+ +..+.+|++..+..++. ..+...+.++++..++..+.......+++.||.+...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~i~~~fg~~~--~~~~~~l~il~~~~~~~~~~~~~~~~l~~~g~~~~~~ 364 (480)
T COG2244 287 KALKKLLRQSLKLLLLISIPALLGLLLLAPPIITLLFGEKY--ASAAPILQLLALAGLFLSLVSLTSSLLQALGKQRLLL 364 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhheeecCCcc--cchhHHHHHHHHHHHHHHHHHHHHHHHHHcCcchhhH
Confidence 99999999999999999999985 57788899877766542 2267789999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHH
Q 013357 202 YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLS 236 (444)
Q Consensus 202 ~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~ 236 (444)
..+.++.++|++++++++.. +|..|++.++ .+
T Consensus 365 ~~~~~~~i~~~~l~~~li~~--~g~~g~~~a~-~~ 396 (480)
T COG2244 365 LISLISALLNLILNLLLIPR--FGLIGAAIAT-AS 396 (480)
T ss_pred HHHHHHHHHHHHHHhHHHHh--hhhhhHHHHH-HH
Confidence 99999999999999999986 6899999988 44
No 33
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=99.51 E-value=1.2e-12 Score=124.80 Aligned_cols=158 Identities=15% Similarity=0.115 Sum_probs=143.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHH
Q 013357 278 SSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSI 357 (444)
Q Consensus 278 p~~~~~~~~~~~~~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~ 357 (444)
|.++.+....+...+++.+++++|++ ++++|+.+.++..+...+..+++++..|.++++.|++|+|+.++..+..+.+
T Consensus 1 p~~~~~~~~~~~~~~~~~~~~~~g~~--~~~~~~~a~~i~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~ 78 (342)
T TIGR00797 1 PAILANILQPLLGLVDTAFVGHLGPV--DLAAVSLGSSVFMFLFSILMGLGTATTALVAQAVGAGNYQRLGRQAQQSLLL 78 (342)
T ss_pred ChHHHHHHHHHHHHHHHHHHhcccHH--HHHHHHHhHHHHHHHHHHHHHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHH
Confidence 67888899999999999999999854 4569999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhhHHH
Q 013357 358 SFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIHLLC 437 (444)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~~ 437 (444)
.++++++.++++.++++++.++++.|++..+.+.++++++++..++.+++.+..+.+|+.||.+...........+++..
T Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~~~~~i~~ 158 (342)
T TIGR00797 79 ALLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIGNVINIIL 158 (342)
T ss_pred HHHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999878888899999999999999999999999999999999888866665555555543
No 34
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.00 E-value=1.3e-09 Score=106.70 Aligned_cols=205 Identities=15% Similarity=0.073 Sum_probs=183.8
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccC--hhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 013357 45 WLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLG--NLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (444)
Q Consensus 45 ~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~lg--~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~ 122 (444)
.+.++++++.+.|..+...++.-...+.....|.++ ..+++..++...... .......|++.++...+++.+|+++.
T Consensus 243 ~~~~~~~~~lai~s~~miclE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~-~~~~~~~~~~~a~strv~neLGag~p 321 (473)
T KOG1347|consen 243 FDSWGPFFALAIPSAVMICLEWWAYEILVLLAGLLGNAKVSLASQSICLEIGG-WHLMIPGAFSAAVSTRVSNELGAGKP 321 (473)
T ss_pred hhhHHHHHHHhhcchheeHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHH-HHHHHhhhhhhhHHHHHHHHHcCCCh
Confidence 788999999999999999999999999999999986 468999999999998 77788889999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHH
Q 013357 123 EMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (444)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 201 (444)
++++.........+...++... .++...+.+...+..++|+.+...+..++++...+.+..+.+..+..+|.|+.+...
T Consensus 322 ~~ar~~~~v~~~~~~~~g~~~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v~~Gva~g~g~q~~ga 401 (473)
T KOG1347|consen 322 KRARVSAKVALQTSVAIGASLGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAVLSGVARGSGWQQIGA 401 (473)
T ss_pred hhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhhhhheEEeeccccceE
Confidence 9999999999999988888887 567788888899999999999999999999999999999999999999999999999
Q ss_pred HHHHHH-HHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHh
Q 013357 202 YISAAT-LVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILM 250 (444)
Q Consensus 202 ~~~~~~-~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~ 250 (444)
+.++.. .++.+++...+-+..++|..|.|.+...+..+..........+
T Consensus 402 ~vnl~~yyl~G~p~g~~l~~~~~~g~~glw~G~~~~~~~~~~~l~~~~~~ 451 (473)
T KOG1347|consen 402 VINLVAYYLVGAPVGLYLGFFTKFGVKGLWIGILLGFSVQTLVLAIVTAR 451 (473)
T ss_pred EEeeeeeeEecCcceeEEEEEEecCceEEEeehHHHHHHHHHHHHHheee
Confidence 999988 5778888878777778999999999999966666666555543
No 35
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=99.00 E-value=2.3e-06 Score=76.60 Aligned_cols=316 Identities=13% Similarity=0.049 Sum_probs=188.1
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-c-C-hhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCC
Q 013357 45 WLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-L-G-NLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGR 121 (444)
Q Consensus 45 ~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~-l-g-~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~ 121 (444)
..+++++.++-.|+.+++....+...+.+.-++| - . .+.+|+|+++..+.- +...+...+-+....++ +++
T Consensus 7 ~~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~l-f~~sp~~~~~~igl~~V-----~s~ 80 (345)
T PF07260_consen 7 LTSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLML-FFASPLSMFHHIGLVFV-----NSK 80 (345)
T ss_pred cchHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHH-HHhChhhhhHHHHHHHh-----cch
Confidence 4578999999999999999999998888888877 3 2 245999999999988 77777776666543333 333
Q ss_pred cchHHHHHHHHHHHHHHHHHHH-H-HHH-HhhHHHH-HHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCc
Q 013357 122 YEMLGVYMQRATFVLLATGVPV-M-MVY-IFCKPML-ILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIV 197 (444)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~-~-~~~-~~~~~i~-~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~ 197 (444)
++ ++....+...+..+...+ . +.+ .+...++ ..++.++++.+.+...+.++.+-.++.++....++++-=.+++
T Consensus 81 rs--rr~~vl~~~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~r~s 158 (345)
T PF07260_consen 81 RS--RRKAVLCMAVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKHRHS 158 (345)
T ss_pred hh--hHHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhccce
Confidence 22 222222333333333222 2 223 2344444 6668899999999999999999999999999999999866777
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcCCcc-chh---HHHHHHHHHHHHHHHH-HHHHhcccccccccccchhhhhhHHHH
Q 013357 198 LPSAYISAATLVLHLLLSWLVVYKFGAGL-IGA---SLVLSLSWYIIVGAQF-AYILMSDKCKHTWTGFSVQAFSGICEF 272 (444)
Q Consensus 198 ~~~~~~~~~~~i~~i~l~~ili~~~~~g~-~g~---~~a~~i~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i 272 (444)
......++...+..+++..+++.. ++.. ..+ ..+...+..+.+.+.. -++..-.+..+.....+.+.-..++++
T Consensus 159 ~iV~~aSI~~v~~qvV~v~~ll~~-~l~~~~pllipil~~y~g~~vr~t~v~LGy~~~i~~~~p~~~~~~~~~~~tl~~~ 237 (345)
T PF07260_consen 159 WIVGSASIADVIAQVVLVAILLSM-HLEPQDPLLIPILALYAGIAVRFTIVCLGYYQSIHDIIPQLSGLEKGDSATLQRM 237 (345)
T ss_pred eEeehHHHHHHHHHHHHHHHHHcc-ccCccccHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhccccCCcccCCChhHHHH
Confidence 776666666665555555455432 1111 222 2223333322222211 122111222222222333333569999
Q ss_pred HHHHhHHHHHHHHHHHHHHHHHHHHhh-cCch---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHH--
Q 013357 273 LKLSGSSAVMLCLETWYFQILVLIAGL-LDNP---ELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKA-- 346 (444)
Q Consensus 273 ~~~~~p~~~~~~~~~~~~~~~~~~~~~-~g~~---~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~-- 346 (444)
+++.+|.+.......+.-.+.+..+++ +++. ..++|+..+.+.+.-..+.-.+-+- +..|..-++--+++..+
T Consensus 238 l~F~~PL~~~~~tq~~SrplVnl~vsR~l~gs~a~~~avavl~~~ypvgh~~y~w~~~~r-~~~paf~~~~~~~~~~~~~ 316 (345)
T PF07260_consen 238 LKFWWPLALVLATQRISRPLVNLFVSRDLSGSQAATEAVAVLTATYPVGHMPYGWLTELR-AVYPAFDKNNPQNKLRNCG 316 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhccCCcccchhhhhhhccccCCCcCcchhHHhHH-hhCchhhccCccccccccc
Confidence 999999999999999999999999988 5543 2455555555554444333333221 23333322211111111
Q ss_pred ---HHHHHHHHHHHHHHHHHHHHHHHH
Q 013357 347 ---AAFSVVVVTSISFIISVVFAVIVL 370 (444)
Q Consensus 347 ---~~~~~~~~~~~~~~~~~~~~~~~~ 370 (444)
.+..+++-....+.+++..++.++
T Consensus 317 ~~v~~~~~~kf~~~c~~~sl~~~f~~f 343 (345)
T PF07260_consen 317 NPVTQSHISKFVVLCLLLSLALCFVMF 343 (345)
T ss_pred CchhHHHHHHHHHHHHHHHHHHHHHHh
Confidence 223555555555555555555443
No 36
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=98.81 E-value=7.1e-06 Score=81.84 Aligned_cols=365 Identities=10% Similarity=-0.004 Sum_probs=202.9
Q ss_pred HhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHH-HHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHH
Q 013357 53 RLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQ-LFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQ 130 (444)
Q Consensus 53 ~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~-~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~~~~ 130 (444)
+-+.-.++.+++..+.+++-+.++-| ++++.+|..++=..+.. .+.+..=.++-.+.+..-.....++|.++..+..+
T Consensus 5 ~gas~li~lQl~sRllTFvlN~lllR~lsp~ilGi~nv~LeLl~sTILFlSRE~fR~A~lR~~~~~~~~~~~~~~~n~~w 84 (549)
T PF04506_consen 5 KGASFLILLQLLSRLLTFVLNQLLLRFLSPEILGIANVQLELLYSTILFLSREAFRRACLRQPSSSIDKSNWAQSINLLW 84 (549)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhCCHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCcccCcccHHHhhhccc
Confidence 34556677788888887776666555 89999998866555554 45556667777775544333311222333333333
Q ss_pred HHHHHHHHHHHHHHHH-H-H--hhHHHH--HHcCCC-HH---HHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHH
Q 013357 131 RATFVLLATGVPVMMV-Y-I--FCKPML--ILLGES-TA---VASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPS 200 (444)
Q Consensus 131 ~~~~~~~~~~~~~~~~-~-~--~~~~i~--~~~~~~-~~---~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 200 (444)
....+..++..+...+ + . .+..+. .+...+ +. ..+.....+.+...+..+..+...+....|..-+.+.-
T Consensus 85 ls~~lq~vvn~~~~~I~l~~igi~~~~~~~~~~~~~~~~~~~~~p~~~~~v~l~~~s~~iELlsEP~~il~Q~~l~~~~R 164 (549)
T PF04506_consen 85 LSVPLQAVVNLICSYIWLAWIGIPLSILLSQYQYASISNAFVIEPYFEPSVFLYGLSAFIELLSEPLYILAQQMLFFKLR 164 (549)
T ss_pred ccCcchhheehhHHHHhHhhccccHHHHHHHHHhhcchhhHHhhhhHHHHHHHHHHHHHHHHhhhHHHHHHHHHhhhhee
Confidence 3333333333322211 1 0 111111 111111 11 12333444555555666655555554444444444443
Q ss_pred HHHHHHHHHHHHHHHHHHHHhc---C--Ccc-----c-hhHHHHHHHHHHHHHHHHHHHHhc--cc---ccccccccch-
Q 013357 201 AYISAATLVLHLLLSWLVVYKF---G--AGL-----I-GASLVLSLSWYIIVGAQFAYILMS--DK---CKHTWTGFSV- 263 (444)
Q Consensus 201 ~~~~~~~~i~~i~l~~ili~~~---~--~g~-----~-g~~~a~~i~~~i~~~~~~~~~~~~--~~---~~~~~~~~~~- 263 (444)
......+...+.+.++.++... + ++. . -+.++...+++...+......... .+ .....++...
T Consensus 165 v~~E~~A~~~k~i~t~~~v~~~~~~~~~~~~~~~~~~~~~~l~Falgq~~ys~~l~~~y~~~~~~~~~~~s~~lp~i~~~ 244 (549)
T PF04506_consen 165 VKAESLAVFAKCIVTFALVVLAERSGYGFFYFLSGQEGLAILAFALGQLAYSITLFFCYYWMYFFPFKSFSDLLPKISSG 244 (549)
T ss_pred eEechHHHHHHHHHHHHHHHHHHhcccceeeeeccchhHHHHHHHHHHHHHHHHHHhhHHhhccCcccchhhcccccccc
Confidence 3333344333333333333221 1 111 1 123455556555544333222111 11 1111121211
Q ss_pred --hhhhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhh--cCchHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHH
Q 013357 264 --QAFSGICEFLKLSGSSAVMLCLETWYFQILVLIAGL--LDNPELALDSLSVCMAVSGLLFM-VSVGFNAAASVRVSNE 338 (444)
Q Consensus 264 --~~~~~~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~--~g~~~~~va~~~~~~~i~~~~~~-~~~~l~~a~~~~i~~~ 338 (444)
+...--+++.+.......+++.-.+..+-+.+++.. +.+.+. -|.|.+++|..++.-= +...+..+.....++.
T Consensus 245 ~~~~~~fd~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~~-QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~ 323 (549)
T PF04506_consen 245 NPKSYYFDRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFED-QGVYALVSNYGSLVARLLFQPIEESSRLYFSKL 323 (549)
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHHH-hhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHH
Confidence 010123678888888899999999999999988888 555333 2599999999877644 3445777777777777
Q ss_pred hcCCCh---------HHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHH
Q 013357 339 LGAGNP---------KAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPV 409 (444)
Q Consensus 339 ~g~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~ 409 (444)
..+++. ++..+.....++....+++.+...-....+.+++++.++.-........+++++...++.+++.+
T Consensus 324 l~~~~~~~~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi 403 (549)
T PF04506_consen 324 LSRDNSKKKQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGI 403 (549)
T ss_pred hcccCchhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccH
Confidence 665433 34566666777777777766666666666777777654332233368899999999999999999
Q ss_pred hhhhhhchh
Q 013357 410 LSGPYMHIF 418 (444)
Q Consensus 410 ~~~~l~~~g 418 (444)
.-+..++..
T Consensus 404 ~EaF~~s~a 412 (549)
T PF04506_consen 404 TEAFVFSVA 412 (549)
T ss_pred HHHHHHHhC
Confidence 999999986
No 37
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=98.60 E-value=7.3e-06 Score=67.55 Aligned_cols=79 Identities=16% Similarity=0.243 Sum_probs=74.0
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHh
Q 013357 171 VYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILM 250 (444)
Q Consensus 171 l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~ 250 (444)
+++++++.++..+.....+.+++.||++..+..+..+.++|+++++++++. +|..|+++|+.+++.+......++.+|
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~~~v~i~~~~~li~~--~G~~Gaa~a~~i~~~~~~~~~~~~~~k 79 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIGAIVNIILNYILIPR--FGIYGAAIATAISEIVSFILNLWYVRK 79 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHHH--HHHhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 578889999999999999999999999999999999999999999999876 799999999999999999999888887
Q ss_pred c
Q 013357 251 S 251 (444)
Q Consensus 251 ~ 251 (444)
+
T Consensus 80 ~ 80 (146)
T PF14667_consen 80 K 80 (146)
T ss_pred H
Confidence 6
No 38
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=98.43 E-value=4.3e-05 Score=76.31 Aligned_cols=203 Identities=14% Similarity=0.094 Sum_probs=162.2
Q ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc--c-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc--
Q 013357 48 LKLLVRLAAPAVFVYLINNLMSLSTRVFCGH--L-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY-- 122 (444)
Q Consensus 48 ~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~--l-g~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~-- 122 (444)
-++.++.....+.+++.-.+.+--|+.++.. + +.++-|.|++++++-++..=.+...+-.+.....++...+++.
T Consensus 252 d~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~~QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~l~~~~~~~ 331 (549)
T PF04506_consen 252 DRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFEDQGVYALVSNYGSLVARLLFQPIEESSRLYFSKLLSRDNSKK 331 (549)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHHHhhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHHhcccCchh
Confidence 5788888999999999999999999999999 5 7889999999999999777788888888888888887765433
Q ss_pred -------chHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHc
Q 013357 123 -------EMLGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQ 194 (444)
Q Consensus 123 -------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~ 194 (444)
++..+.+...+++...+++++. ......+.++.+++.+.-..+.+.+.++..+..+|+.+++.+..++.++.
T Consensus 332 ~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi~EaF~~s~ 411 (549)
T PF04506_consen 332 KQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGITEAFVFSV 411 (549)
T ss_pred hccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccHHHHHHHHh
Confidence 3355666667777777776665 34566777777776544334445778999999999999999999999999
Q ss_pred CCchHHHHHH---HHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 195 SIVLPSAYIS---AATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 195 g~~~~~~~~~---~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
...+.....+ .+..++.+..+++++.. ++|..|..+|.++.+.+..+...++.++.
T Consensus 412 a~~~~l~~~~~~m~~~S~~f~~~~~~l~~~-~~G~~GlI~AN~iNM~lRI~ys~~fI~~~ 470 (549)
T PF04506_consen 412 ASESQLDRYNYWMVVFSAIFLAASYLLTRW-GLGAVGLILANCINMSLRIIYSLRFIRRY 470 (549)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 8776655444 44467777888888886 78999999999999999998888887664
No 39
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=98.43 E-value=0.00082 Score=63.39 Aligned_cols=363 Identities=10% Similarity=0.030 Sum_probs=198.9
Q ss_pred HHHHHHHhhHHHHHHHHHHHHHHHH-HHHHHhccChhHHHHHHHHHHHHH-HHHHHHHHHHHHhHHHHHHhhhcCCCcch
Q 013357 47 ELKLLVRLAAPAVFVYLINNLMSLS-TRVFCGHLGNLELAAASLGNSGIQ-LFAYGLMLGMGSAVETLCGQAYGAGRYEM 124 (444)
Q Consensus 47 ~~~~il~~~~p~~~~~~~~~~~~~~-~~~~i~~lg~~~~a~~~~a~~~~~-~~~~~~~~gl~~~~~~~~s~~~g~~~~~~ 124 (444)
...+..+.+...+..+++..+.++. +...+.+++++.+|..++-..+.. .+.+..-.++.-+..+.-++. +++.++
T Consensus 6 vL~ss~~ga~~~i~~Q~~~RiiTF~lN~~liR~~s~~v~gi~nvrl~lL~sTiLFlsREair~A~l~~gs~~--~d~~te 83 (530)
T KOG2864|consen 6 VLESSFSGAVFSIRGQLLARIITFALNALLIRFLSPEVLGIVNVRLELLQSTILFLSREAIRLAELRIGSEP--ADTWTE 83 (530)
T ss_pred HHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHcChhheehhHHHHHHHHHHHHHhhHHHHHHHhccCCCCC--CccHHH
Confidence 3444555556666777777766665 455555589999999988777666 334444445554433322221 112334
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHH-HHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHH
Q 013357 125 LGVYMQRATFVLLATGVPVMMVYIFCKPMLILLGESTA-VASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYI 203 (444)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 203 (444)
..+..+.+..+..+..+...-+++ .+.. ..|+. ..+.-..-..+...+.....+...+.-..|..-+.+.-.+.
T Consensus 84 ~~n~~wlS~~L~~~i~~~~i~~wl---~~~~--s~d~i~~~p~y~~~I~~~~~S~vvELlsEp~~iv~Q~~~~~~~~~i~ 158 (530)
T KOG2864|consen 84 FINLLWLSVPLQTAINVACIYFWL---GFLS--SSDEISYSPLYAFAIFIIGLSIVVELLSEPLYIVSQCGLKVQLRAIA 158 (530)
T ss_pred HHHhhhhhhhHHHHHHHHHHHHHH---HHhh--ccchhhcCchHhHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHHHH
Confidence 555555555444444443332211 1110 01111 12222233445555566666666666667777777777777
Q ss_pred HHHHHHHHHHHHHHHHHhc--CCccchhHHHHHHHHHHHHHHHHHHHHhccccc----------ccccccchh--hhhhH
Q 013357 204 SAATLVLHLLLSWLVVYKF--GAGLIGASLVLSLSWYIIVGAQFAYILMSDKCK----------HTWTGFSVQ--AFSGI 269 (444)
Q Consensus 204 ~~~~~i~~i~l~~ili~~~--~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~----------~~~~~~~~~--~~~~~ 269 (444)
.-+..++.-...+...... .+++..-++|.........+..++++.+.++-+ ...++.... ...--
T Consensus 159 e~l~~~v~~i~~fa~lv~~~~~~~l~~FAlaql~~~itl~l~y~~~Yf~~~~s~~~~~~~~r~Sdllpk~~~n~~~~ffd 238 (530)
T KOG2864|consen 159 EGLATIVKCIVLFAGLVMGPNMYALLAFALAQLAYAITLLLCYYWFYFYIRGSIPETEPFSRFSDLLPKVSENERGIFFD 238 (530)
T ss_pred hHHHHHHHHHHHHHHHHhcCchhHHHHHHHHHHHhhHHHHHHHHHHHHHHcCCcccccchhhhhhhccCCCCCCcccccc
Confidence 7777766644433333321 144444555555554444443333333322200 001111000 00012
Q ss_pred HHHHHHHhHHHHHHHHHHHHHHHHHHHHhhc---CchHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhcCCChH
Q 013357 270 CEFLKLSGSSAVMLCLETWYFQILVLIAGLL---DNPELALDSLSVCMAVSGLLFM-VSVGFNAAASVRVSNELGAGNPK 345 (444)
Q Consensus 270 ~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~---g~~~~~va~~~~~~~i~~~~~~-~~~~l~~a~~~~i~~~~g~~~~~ 345 (444)
++..+.......+.+.-++...-+..+++.. .-++.+ .|.+++|..++..- +...+-.......+|...+++.|
T Consensus 239 ~d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~Qg--vYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe 316 (530)
T KOG2864|consen 239 NDLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQG--VYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQE 316 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhh--HHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchh
Confidence 2344444445555566666666666555532 223555 88888888766554 45667788888888888877777
Q ss_pred HHHHHHH---HHHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchh
Q 013357 346 AAAFSVV---VVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIF 418 (444)
Q Consensus 346 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g 418 (444)
+.|+... ..++....+++.....-.-.++.++.+++++.-....+...++++++..++.+++.+..+..++.+
T Consensus 317 ~~k~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEaF~~A~~ 392 (530)
T KOG2864|consen 317 NVKKAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEAFAFAVA 392 (530)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHHHHHHhc
Confidence 7666554 444444444444444444555566676654322222256889999999999999999999999987
No 40
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=97.89 E-value=0.0067 Score=57.48 Aligned_cols=200 Identities=16% Similarity=0.133 Sum_probs=143.3
Q ss_pred HHHHhhHHHHHHHHHHHHHHHHHHHHHhc---cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHH
Q 013357 50 LLVRLAAPAVFVYLINNLMSLSTRVFCGH---LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLG 126 (444)
Q Consensus 50 ~il~~~~p~~~~~~~~~~~~~~~~~~i~~---lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~ 126 (444)
+..+......-+.+.-.+.+=-|+++++- ++-++-|.|.+.+++-++..-.+...+--......+|...+++.|+.+
T Consensus 240 d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~QgvYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe~~k 319 (530)
T KOG2864|consen 240 DLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQGVYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQENVK 319 (530)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhhHHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchhhHH
Confidence 44445555566777777888888888874 366678888888888887777777778777778888877777666655
Q ss_pred HHH---HHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHH-
Q 013357 127 VYM---QRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA- 201 (444)
Q Consensus 127 ~~~---~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~- 201 (444)
+.. ...+.+...+++... ....-.++.+.+++.+.-....+...+++.+..+|+.+++.+..++..+.+..+..-
T Consensus 320 ~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEaF~~A~~t~~qi~~ 399 (530)
T KOG2864|consen 320 KAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEAFAFAVATSRQIDK 399 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHHHHHHhccHHHHHh
Confidence 544 444554444554433 234455566666665543344455789999999999999999999999987665543
Q ss_pred --HHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 013357 202 --YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (444)
Q Consensus 202 --~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (444)
....+..++.++.+++++-++ |..|..+|.++.+.+.-+....+.++.
T Consensus 400 ~n~~mlafSviflilsylL~~~~--~~~GlIlANiiNm~lRIlys~~fI~~~ 449 (530)
T KOG2864|consen 400 HNKFMLAFSVIFLILSYLLIRWF--GLVGLILANIINMSLRILYSLRFIRHY 449 (530)
T ss_pred cccchhHHHHHHHHHHHHHHHHh--chhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 345556778889999999884 679999999999988877776666554
No 41
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=97.42 E-value=0.00085 Score=61.28 Aligned_cols=72 Identities=18% Similarity=0.128 Sum_probs=67.5
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhh
Q 013357 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQA 116 (444)
Q Consensus 44 ~~~~~~~il~~~~p~~~~~~~~~~~~~~~~~~i~~-lg~~~~a~~~~a~~~~~~~~~~~~~gl~~~~~~~~s~~ 116 (444)
+++..|++++.+.|..++++...+....|+.++++ .|++++|.|+.+.++.. ....+...+.+...|.+++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ii~~~~g~~~vg~Y~~a~~l~~-~~~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 200 SKKFFKEILRFGLPLFLSSLLSWLYSQIDRLIIGYFLGPEAVGIYSVAYRLAS-AISFLLSSISTVLFPRLSRL 272 (273)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHhCCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHh
Confidence 47789999999999999999999999999999999 69999999999999999 88888999999999999875
No 42
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=97.26 E-value=0.029 Score=50.97 Aligned_cols=144 Identities=13% Similarity=0.101 Sum_probs=102.0
Q ss_pred hhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhhc-CchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCh
Q 013357 266 FSGICEFLKLSGSSAVMLCLETWYFQILVLIAGLL-DNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNP 344 (444)
Q Consensus 266 ~~~~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~-g~~~~~va~~~~~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~ 344 (444)
...+++++++.+|.+++.....+.-++.+.-+++- -+....+|+|+++..+.-++..+...+-+.....+.. ++
T Consensus 7 ~~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~~sp~~~~~~igl~~V~s-----~r 81 (345)
T PF07260_consen 7 LTSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFFASPLSMFHHIGLVFVNS-----KR 81 (345)
T ss_pred cchHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHHhChhhhhHHHHHHHhcc-----hh
Confidence 35688999999999999999999999988888763 3444557899999999999999988888866665532 22
Q ss_pred HHHHHHHHHHHHHHHHHHHH-HHHHHHHhhhh-hhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhh
Q 013357 345 KAAAFSVVVVTSISFIISVV-FAVIVLALRHV-ISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYM 415 (444)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~ 415 (444)
+ -++........+.+.... ..+..--+++. +-+++.-||++.+.+...+.++.+..+++++....++++-
T Consensus 82 s-rr~~vl~~~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILi 153 (345)
T PF07260_consen 82 S-RRKAVLCMAVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILI 153 (345)
T ss_pred h-hHHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhh
Confidence 2 223333333222222222 11112222222 3344677899999999999999999999999999998876
No 43
>COG4267 Predicted membrane protein [Function unknown]
Probab=97.07 E-value=0.26 Score=45.90 Aligned_cols=266 Identities=11% Similarity=0.046 Sum_probs=146.8
Q ss_pred HHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHh
Q 013357 97 FAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIP 176 (444)
Q Consensus 97 ~~~~~~~gl~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~ 176 (444)
+...+..|+.-.++..+|...=+||.+++..-..-...+....+.++.. ++-...++.... |=.....
T Consensus 72 fS~IiTgg~q~iiTRfiSD~lF~k~~~kIlpsy~Gvi~lv~~~a~~ig~-------~vf~~~~~~si~-----yk~l~~~ 139 (467)
T COG4267 72 FSQIITGGFQLIITRFISDCLFEKKQRKILPSYIGVILLVTLVAGVIGL-------IVFFVNNQYSIV-----YKILACA 139 (467)
T ss_pred HHHHHhhhHHHHHHHHHHHHHHHHHHHHHhHhHHHHHHHHHHHHHHHHH-------HhhhhcCchhHH-----HHHHHHH
Confidence 4455566777777788887777777666644443333333222222221 111112222111 2223334
Q ss_pred hHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHHhcccccc
Q 013357 177 QIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKH 256 (444)
Q Consensus 177 ~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~ 256 (444)
.............++.+.+|.+...+.-.++.++.+.+..++-. .+..|..++..++..+.......+..|.-+-+
T Consensus 140 ~FV~m~~~Wi~~iFlS~lK~y~~iv~sF~iG~~~sv~La~~~~~---~~ie~lLL~~~IGi~~i~~l~~~~Ilr~fk~~- 215 (467)
T COG4267 140 LFVGMSLVWILMIFLSGLKKYKLIVLSFFIGYVVSVLLARLFLK---SPIEGLLLTLDIGIFIILFLLNFYILRYFKSS- 215 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hHHHHHHHHHHHhHHHHHHHHHHHHHHhcccc-
Confidence 45556666777889999999999999999999888888777654 58999999999999988888777776651111
Q ss_pred cccccchhhhhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhhcCchHHH------HHHHHHHHHHHHHHHHHHH-----
Q 013357 257 TWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYFQILVLIAGLLDNPELA------LDSLSVCMAVSGLLFMVSV----- 325 (444)
Q Consensus 257 ~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~------va~~~~~~~i~~~~~~~~~----- 325 (444)
+...++.-. .. +.-....+-.+...+.-.+++.+.=.-++++.- ---|.+..-...+...|..
T Consensus 216 ~~i~FdFL~--~~----~~y~SLllIg~FY~lgiwid~FifW~~~~~~~Iag~~~~S~lYDvpiF~ayl~~iPs~vvF~i 289 (467)
T COG4267 216 RRIGFDFLL--YR----RKYPSLLLIGFFYNLGIWIDNFIFWKVPTGIEIAGPFFASPLYDVPIFYAYLFIIPSMVVFLI 289 (467)
T ss_pred cccceehhh--hh----hcchHHHHHHHHHHhHhhhhheeeEecCCCCEeecceecchhhhHHHHHHHHHhcchhheeee
Confidence 112233221 11 111122333444455555554433221211110 0123333333333333322
Q ss_pred HHHHHHHHHHHHHhc----C-------CChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhccCcH
Q 013357 326 GFNAAASVRVSNELG----A-------GNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGE 384 (444)
Q Consensus 326 ~l~~a~~~~i~~~~g----~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~ 384 (444)
.+.+...+.--+.+. . ++.++.....|+.+.-.+-+-...++.++++++.+...+.-++
T Consensus 290 ~lET~F~~~Yk~~y~~I~~g~tl~~I~~~~~kMiltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~ 359 (467)
T COG4267 290 SLETDFQENYKEYYQAIRGGGTLREIENNLKKMILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSE 359 (467)
T ss_pred eeeehHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHH
Confidence 222333333222211 1 2345566667777777888888899999999999998886544
No 44
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=96.40 E-value=0.3 Score=43.81 Aligned_cols=128 Identities=16% Similarity=0.240 Sum_probs=79.4
Q ss_pred HHHHHHHhhcCchHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHH
Q 013357 291 QILVLIAGLLDNPELALDSLSVCMAVSGLLFMV-SVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIV 369 (444)
Q Consensus 291 ~~~~~~~~~~g~~~~~va~~~~~~~i~~~~~~~-~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (444)
.....+...+|.++. |.|+....+..+...+ ..|+.+...- ..++|+++.++..+.......+..++..++.
T Consensus 6 ~~~~~lar~l~~~~~--G~~~~~~s~~~~~~~~~~~g~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (251)
T PF13440_consen 6 LFLILLARYLGPEDF--GIYALIFSIVSILSIVASLGLRQSLVR-----SAARDKQDIRSLLRFSLLVSLLLAVILAILA 78 (251)
T ss_pred HHHHHHHHHCCHHHh--HHHHHHHHHHHHHHHHHHHHHHHHHHH-----hhccCHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 344455566676554 4899988888877776 4455444322 3346677777777776665555554444433
Q ss_pred HHhhhhhhhhccCcHHHHHHHHHHhHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhh
Q 013357 370 LALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIH 434 (444)
Q Consensus 370 ~~~~~~l~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~ 434 (444)
.... ..+ ++++ ....+.+..+..++...+....+.+++.+|............+..
T Consensus 79 ~~~~----~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 134 (251)
T PF13440_consen 79 ILIA----YFF-GDPE----LFWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRSLLR 134 (251)
T ss_pred HHHH----HHh-CChh----HHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHH
Confidence 2222 233 3333 345566677778888999999999999998777655554444444
No 45
>COG4267 Predicted membrane protein [Function unknown]
Probab=86.81 E-value=24 Score=33.42 Aligned_cols=117 Identities=12% Similarity=0.216 Sum_probs=74.5
Q ss_pred HHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHH
Q 013357 125 LGVYMQRATFVLLATGVPVM-MVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYI 203 (444)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 203 (444)
.....++.+.-..-+....+ .+++.++.+..+++-++...+ .+++-.++.........+-+..--.++-+.....
T Consensus 322 Miltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~~~l~----lF~vd~lg~s~~i~f~~ll~i~lyfd~r~i~l~~ 397 (467)
T COG4267 322 MILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSEYYLD----LFYVDVLGVSCQIVFMSLLNIFLYFDYRRIALEL 397 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 33444444444444455555 567888999999987764443 5666666666666666666666667777888888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHH
Q 013357 204 SAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYI 248 (444)
Q Consensus 204 ~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~ 248 (444)
+..-.+.|-++++++... |-+..|+.. .++.++...+.....
T Consensus 398 t~~fli~N~ilT~i~l~l-gp~~~g~gf--f~a~fl~vlv~~~~l 439 (467)
T COG4267 398 TALFLISNGILTFIFLEL-GPGYYGVGF--FLASFLYVLVAFKSL 439 (467)
T ss_pred hhHHHHHhHHHHHHHHHh-CccceehHH--HHHHHHHHHHHHhhh
Confidence 888889999999888764 455655543 444444444444333
No 46
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=76.57 E-value=3.5 Score=33.33 Aligned_cols=49 Identities=12% Similarity=0.209 Sum_probs=42.6
Q ss_pred hHHHHHHHHHhhHHHHhhhhhhchhhHHHHHHhhcccchhhHHHHHhhh
Q 013357 394 CPLLALTLLLNGVQPVLSGPYMHIFLIFFTCVMKWNNSKIHLLCYNQLM 442 (444)
Q Consensus 394 l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 442 (444)
+++++++.++.+++...++++++.||++...........+++..-+.+.
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~~~v~i~~~~~li 50 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIGAIVNIILNYILI 50 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHH
Confidence 6788999999999999999999999999998888888888887655543
No 47
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=69.32 E-value=33 Score=24.79 Aligned_cols=42 Identities=17% Similarity=0.067 Sum_probs=31.3
Q ss_pred HHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHH
Q 013357 323 VSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVV 364 (444)
Q Consensus 323 ~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 364 (444)
+..-++-.....+.+.+.+||++++++..+++.+++.+-...
T Consensus 32 PlGi~Ai~~s~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~~~ 73 (82)
T PF04505_consen 32 PLGIVAIVYSSKVRSRYAAGDYEGARRASRKAKKWSIIAIII 73 (82)
T ss_pred hHHHHHheechhhHHHHHCCCHHHHHHHHHHhHHHHHHHHHH
Confidence 334444555667888899999999999999999888654443
No 48
>KOG0569 consensus Permease of the major facilitator superfamily [Carbohydrate transport and metabolism]
Probab=46.95 E-value=3.1e+02 Score=27.48 Aligned_cols=34 Identities=9% Similarity=0.164 Sum_probs=22.7
Q ss_pred cCCchHHHHHHHHHHHHHHHHHHHHHHhcCCccchh
Q 013357 194 QSIVLPSAYISAATLVLHLLLSWLVVYKFGAGLIGA 229 (444)
Q Consensus 194 ~g~~~~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~ 229 (444)
.-|.....+.....++.|.+....+.+. ....|.
T Consensus 400 ~~R~aa~s~~~~~~w~~~fiv~~~fp~l--~~~~g~ 433 (485)
T KOG0569|consen 400 SARSAAQSVATAVNWLSNFIVGFAFPPL--QNVIGP 433 (485)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHH--HHHhcc
Confidence 3455666666777788888887777665 355665
No 49
>PRK03612 spermidine synthase; Provisional
Probab=45.47 E-value=3.4e+02 Score=27.51 Aligned_cols=50 Identities=16% Similarity=0.037 Sum_probs=27.5
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcCCccchhHHHHHHHHHHHHHHHHHHHH
Q 013357 198 LPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYIL 249 (444)
Q Consensus 198 ~~~~~~~~~~~i~~i~l~~ili~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~ 249 (444)
+....-++.+.+-.++..+++++. +|..+..+....-++...++..+..+
T Consensus 149 ~ly~~ntlGa~~G~l~~~~vLlp~--lG~~~t~~~~a~l~~~~a~~~~~~~~ 198 (521)
T PRK03612 149 TVLAADYLGALVGGLAFPFLLLPR--LGLIRTAALTGSLNLLAALVFLWLFR 198 (521)
T ss_pred hhHhHHhHHHHHHHHHHHHHHHHh--cchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 344444445556666777777766 57666655554444444444444333
No 50
>PF02487 CLN3: CLN3 protein; InterPro: IPR003492 Batten's disease, the juvenile variant of neuronal ceroid lipofuscionosis (NCL), is a recessively inherited disorder affecting children of 5-10 years of age. The disease is characterised by progressive loss of vision, seizures and psychomotor disturbances. Biochemically, the disease is characterised by lysosomal accumulation of hydrophobic material, mainly ATP synthase subunit C, largely in the brain but also in other tissues. The disease is fatal within a decade []. Mutations in the CLN3 gene are believed to cause Batten's disease []. The CLN3 gene, with a predicted 438-residue product, maps to chromosome p16p12.1. The gene contains at least 15 exons spanning 15kb and is highly conserved in mammals []. A 1.02kb deletion in the CLN3 gene, occurring in either one or both alleles, is found in 85% of Batten disease chromosomes causing a frameshift generating a predicted translated product of 181 amino acid residues [, ]. 22 other mutations, including deletions, insertions and point mutations, have been reported. It has been suggested that such mutations result in severely truncated CLN3 proteins, or affect its structure/conformation [, ]. CLN3 proteins, which are believed to associate in complexes, are heavily glycosylated lysosomal membrane proteins [], containing complex Asn-linked oligosaccharides []. Extensive glycosylation is important for the stability of these lysosomal proteins in the highly hydrolytic lysosomal lumen. Lysosomal sequestration of active lysosomal enzymes, transport of degraded molecules from the lysosomes, and fusion and fission between lysosomes and other organelles. The CLN3 protein is a 43kDa, highly hydrophobic, multi-transmembrane (TM), phosphorylated protein []. Hydrophobicity analysis predicts 6-9 TM segments, suggesting that CLN3 is a TM protein that may function as a chaperone or signal transducer. The majority of putative phosphorylation sites are found in the N-terminal domain, encompassing 150 residues []. Phosphorylation is believed to be important for membrane compartment interaction, in the formation of functional complexes, and in regulation and interactions with other proteins []. CLN3 contains several motifs that may undergo lipid post-translational modifications (PTMs). PTMs contribute to targeting and anchoring of modified proteins to distinct biological membranes []. There are three general classes of lipid modification: N-terminal myristoylation, C-terminal prenylation, and palmitoylation of cysteine residues. Such modifications are believed to be a common form of PTM occurring in 0.5% of all cellular proteins, including brain tissue []. The C terminus of the CLN3 contains various lipid modification sites: C435, target for prenylation; G419, target for myristoylation; and C414, target for palmitoylation []. Prenylation results in protein hydrophobicity, influences interaction with upstream regulatory proteins and downstream effectors, facilitates protein-protein interaction (multisubunit assembly) and promotes anchoring to membrane lipids. The prenylation motif, Cys-A-A-X, is highly conserved within CLN3 protein sequences of different species []. Species with known CLN3 protein homologues include: Homo sapiens, Canis familiaris, Mus musculus, Saccharomyces cerevisiae and Drosophila melanogaster.; GO: 0016020 membrane
Probab=41.88 E-value=53 Score=31.91 Aligned_cols=29 Identities=21% Similarity=0.305 Sum_probs=22.4
Q ss_pred hHHHHHHHHHHHHhhHHHHHHHHHHHHHH
Q 013357 41 QIASWLELKLLVRLAAPAVFVYLINNLMS 69 (444)
Q Consensus 41 ~~~~~~~~~~il~~~~p~~~~~~~~~~~~ 69 (444)
.+.+.+..|.++++.+|+.+..+.+...+
T Consensus 235 ~~~k~~~~k~Ll~ymiPL~lVY~aEY~In 263 (402)
T PF02487_consen 235 FKEKLKRLKPLLWYMIPLFLVYFAEYFIN 263 (402)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34456678888889999998888887653
No 51
>TIGR03753 blh_monoox beta-carotene 15,15'-monooxygenase, Brp/Blh family. This integral membrane protein family includes Brp (bacterio-opsin related protein) and Blh (Brp-like protein). Bacteriorhodopsin is a light-driven proton pump with a covalently bound retinal cofactor that appears to be derived beta-carotene. Blh has been shown to cleave beta-carotene to product two all-trans retinal molecules. Mammalian enzymes with similar enzymatic function are not multiple membrane spanning proteins and are not homologous.
Probab=38.21 E-value=3.1e+02 Score=24.87 Aligned_cols=23 Identities=13% Similarity=0.128 Sum_probs=18.8
Q ss_pred HHHHhhcccchhhHHHHHhhhcC
Q 013357 422 FTCVMKWNNSKIHLLCYNQLMHA 444 (444)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~ 444 (444)
........+....+..|+|++|+
T Consensus 165 L~~~f~~lppl~aF~~YFc~wHS 187 (259)
T TIGR03753 165 LLALFALLPPLVAFGLYFCLWHS 187 (259)
T ss_pred HHHHHHHhhHHHHHHHHHHhhcc
Confidence 33566788889999999999995
No 52
>PF01914 MarC: MarC family integral membrane protein; InterPro: IPR002771 Members of this family are integral membrane proteins that includes the antibiotic resistance protein MarC. These proteins may be transporters. ; GO: 0016021 integral to membrane
Probab=38.18 E-value=2.7e+02 Score=24.15 Aligned_cols=60 Identities=12% Similarity=0.014 Sum_probs=39.2
Q ss_pred HHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhH
Q 013357 332 SVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCP 395 (444)
Q Consensus 332 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~ 395 (444)
.|.....-++.+.++.|+..++.....+ .+.+.+.++++++.+.|.-+-+..+.+...+.
T Consensus 21 ip~f~~lt~~~~~~~r~~ia~~a~~~a~----~ill~f~~~G~~iL~~fgIsl~af~IaGGiiL 80 (203)
T PF01914_consen 21 IPIFLSLTKGMSPKERRRIARRASIIAF----IILLIFAFFGQLILNFFGISLPAFRIAGGIIL 80 (203)
T ss_pred HHHHHHHhCCCCHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHH
Confidence 3445555555666666666666554444 56667788999999999766665666555543
No 53
>PRK10739 putative antibiotic transporter; Provisional
Probab=37.92 E-value=2.7e+02 Score=24.06 Aligned_cols=61 Identities=10% Similarity=-0.004 Sum_probs=40.4
Q ss_pred HHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHH
Q 013357 332 SVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPL 396 (444)
Q Consensus 332 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i 396 (444)
.|..-..-.+.++++.|+..++.....+ .+.+++.++++.+.+.|+-+.+....+...+..
T Consensus 21 ipiflslt~~~~~~~r~~ia~~a~~~a~----~ill~f~~~G~~iL~~fGIsl~afrIAGGilL~ 81 (197)
T PRK10739 21 LPIFMSVLKHLEPKRRRAIMIRELLIAL----LVMLVFLFAGEKILAFLNLRTETVSISGGIILF 81 (197)
T ss_pred HHHHHHHhCCCCHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence 3455555555667777777776555444 555577889999999998776666666655443
No 54
>PF03904 DUF334: Domain of unknown function (DUF334); InterPro: IPR005602 This is a family of proteins found in Staphylococcus aureus plasmid with no characterised function.
Probab=37.65 E-value=1.3e+02 Score=26.28 Aligned_cols=61 Identities=8% Similarity=0.002 Sum_probs=31.7
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCH---------HHHHHHHHHHHHHHhhHHHHH
Q 013357 122 YEMLGVYMQRATFVLLATGVPVMMVYIFCKPMLILLGEST---------AVASAAALFVYGLIPQIFAYA 182 (444)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---------~~~~~~~~~l~i~~~~~~~~~ 182 (444)
++...+.+..++...+++.++.++++.+..++.++++.+- +..+....|+++++.++|...
T Consensus 143 y~k~~k~~~~gi~aml~Vf~LF~lvmt~g~d~m~fl~v~~ly~~ia~~ik~se~~~~~lwyi~Y~vPY~~ 212 (230)
T PF03904_consen 143 YQKRQKSMYKGIGAMLFVFMLFALVMTIGSDFMDFLHVDHLYKAIASKIKASESFWTYLWYIAYLVPYIF 212 (230)
T ss_pred HHHHHHHHHHhHHHHHHHHHHHHHHHHhcccchhhhhHHHHHHHHHHHHhhhHhHHHHHHHHHHhhHHHH
Confidence 3444444444544444444444456667777777776431 112234556666666666544
No 55
>PF03609 EII-Sor: PTS system sorbose-specific iic component; InterPro: IPR004700 Bacterial PTS transporters transport and concomitantly phosphorylate their sugar substrates, and typically consist of multiple subunits or protein domains.The Man family is unique in several respects among PTS permease families. It is the only PTS family in which members possess a IID protein. It is the only PTS family in which the IIB constituent is phosphorylated on a histidyl rather than a cysteyl residue. Its permease members exhibit broad specificity for a range of sugars, rather than being specific for just one or a few sugars. The mannose permease of Escherichia coli, for example, can transport and phosphorylate glucose, mannose, fructose, glucosamine, N-acetylglucosamine, and other sugars. Other members of this can transport sorbose, fructose and N-acetylglucosamine. This family is specific for the sorbose-specific IIC subunits of this family of PTS transporters.; GO: 0009401 phosphoenolpyruvate-dependent sugar phosphotransferase system, 0016021 integral to membrane
Probab=34.04 E-value=3.4e+02 Score=24.20 Aligned_cols=68 Identities=15% Similarity=0.013 Sum_probs=46.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHH-HHHHHHhhhhhhhhc
Q 013357 313 CMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVF-AVIVLALRHVISYAF 380 (444)
Q Consensus 313 ~~~i~~~~~~~~~~l~~a~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~ 380 (444)
...+.+........++.....+.-+...++|.++.++....+........... .++...++.+..+-+
T Consensus 102 v~~lg~~l~~~~~~~n~~~~~~adk~ae~gn~~~i~~~~~~~~~~~~~~~~v~~~fl~~~~G~~~v~~~ 170 (238)
T PF03609_consen 102 VGILGQQLDNLLRTINSFFVHRADKAAEEGNYKKINRIHWIGPILFFLIYFVPPVFLAVYFGSDAVQAL 170 (238)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHH
Confidence 33444555556667788888888888999999998888777765555555554 566566666655544
No 56
>PF11947 DUF3464: Protein of unknown function (DUF3464); InterPro: IPR021855 This family of proteins are functionally uncharacterised. This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 137 to 196 amino acids in length.
Probab=27.47 E-value=3.5e+02 Score=22.25 Aligned_cols=24 Identities=8% Similarity=0.081 Sum_probs=15.8
Q ss_pred HHHHHHhhHHHHHHHHHHHHHHHH
Q 013357 48 LKLLVRLAAPAVFVYLINNLMSLS 71 (444)
Q Consensus 48 ~~~il~~~~p~~~~~~~~~~~~~~ 71 (444)
-|-.+..++|.+++.....+...+
T Consensus 63 rRm~~~~GiP~~lG~~~f~~~y~l 86 (153)
T PF11947_consen 63 RRMAVFVGIPTALGVAVFVVFYYL 86 (153)
T ss_pred HHHHHHhchHHHHHHHHHHHHHHH
Confidence 334455678998888777665544
No 57
>PRK11111 hypothetical protein; Provisional
Probab=26.58 E-value=4.4e+02 Score=23.08 Aligned_cols=61 Identities=8% Similarity=-0.048 Sum_probs=38.0
Q ss_pred HHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHH
Q 013357 333 VRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLL 397 (444)
Q Consensus 333 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~ 397 (444)
|..-..-...+.++.++..++.... ...+.+++.++++++.++|+=+-+....+..++...
T Consensus 28 piflslt~~~s~~~r~~ia~~a~l~----a~~ill~f~~~G~~iL~~fGIsl~afrIaGGiiL~~ 88 (214)
T PRK11111 28 PVFISMTSHQTAAERNKTNLTANLS----VAIILLISLFLGDFILNLFGISIDSFRIAGGILVVT 88 (214)
T ss_pred HHHHHHhCCCCHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHH
Confidence 3444444445666666666655544 445555778899999999976666666666555433
No 58
>PF14184 YrvL: Regulatory protein YrvL
Probab=26.48 E-value=3.4e+02 Score=21.71 Aligned_cols=101 Identities=12% Similarity=0.139 Sum_probs=53.5
Q ss_pred HHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHH-HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHH
Q 013357 132 ATFVLLATGVPVMMVYIFCKPMLILLGESTAV-ASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVL 210 (444)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~ 210 (444)
.....+...++.+...+....+++++|-+-|- .....-.+.+...+.|+..+...+...+.-.+-++.. .......+
T Consensus 7 ~i~~~l~~~~v~a~~ff~~~gif~L~Gi~Y~S~~~llLF~li~~~lg~~~e~~~k~l~~~l~~~~~~~~~--~~~l~~~i 84 (132)
T PF14184_consen 7 FIIIALLLIIVFAIYFFVMVGIFHLLGIEYESVGSLLLFFLIIFVLGLPFELFEKVLLKALLFLRMSRRL--FILLAFII 84 (132)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhCcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCchHH--HHHHHHHH
Confidence 33444444444445556666777888765332 2223333445566777777777776666655222222 12334566
Q ss_pred HHHHHHHHHHhcCCccchhHHHHH
Q 013357 211 HLLLSWLVVYKFGAGLIGASLVLS 234 (444)
Q Consensus 211 ~i~l~~ili~~~~~g~~g~~~a~~ 234 (444)
...+++..++.-+.=+.++.+.+.
T Consensus 85 d~~~t~~~i~~aD~~m~sI~is~~ 108 (132)
T PF14184_consen 85 DFLFTWITIYTADELMESISISTL 108 (132)
T ss_pred HHHHHHHHHHHHHHHhcceeeCcH
Confidence 677777777654433444444333
No 59
>PF15461 BCD: Beta-carotene 15,15'-dioxygenase
Probab=26.36 E-value=4.9e+02 Score=23.55 Aligned_cols=21 Identities=14% Similarity=0.180 Sum_probs=17.8
Q ss_pred HHhhcccchhhHHHHHhhhcC
Q 013357 424 CVMKWNNSKIHLLCYNQLMHA 444 (444)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~ 444 (444)
......+....+..|++++|+
T Consensus 162 ~~f~~lppl~af~lYFc~wHS 182 (259)
T PF15461_consen 162 ALFALLPPLVAFALYFCLWHS 182 (259)
T ss_pred HHHHHhcHHHHHHHHHHHHhh
Confidence 556678889999999999996
No 60
>TIGR00383 corA magnesium Mg(2+) and cobalt Co(2+) transport protein (corA). The article in Microb Comp Genomics 1998;3(3):151-69 (Medline:98448512) discusses this family and suggests that some members may have functions other than Mg2+ transport.
Probab=26.24 E-value=3.3e+02 Score=25.33 Aligned_cols=21 Identities=10% Similarity=0.069 Sum_probs=11.7
Q ss_pred HHHHHHHHHHHHHHHHHhccc
Q 013357 233 LSLSWYIIVGAQFAYILMSDK 253 (444)
Q Consensus 233 ~~i~~~i~~~~~~~~~~~~~~ 253 (444)
.....++.++..+++++||+|
T Consensus 297 ~l~~m~~i~~~~~~~fkrk~W 317 (318)
T TIGR00383 297 VLIVMAVIALGPLIYFRRKGW 317 (318)
T ss_pred HHHHHHHHHHHHHHHHHHcCC
Confidence 333344445566677777644
No 61
>TIGR00427 membrane protein, MarC family. MarC is a protein that spans the plasma membrane multiple times and once was thought to be a multiple antibiotic resistance protein. The function for this family is unknown.
Probab=23.64 E-value=4.8e+02 Score=22.53 Aligned_cols=62 Identities=10% Similarity=-0.062 Sum_probs=39.9
Q ss_pred HHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhHHH
Q 013357 332 SVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLL 397 (444)
Q Consensus 332 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~i~ 397 (444)
.|.....-++.+.++.++..++.....+ .+.+.+.++++.+.+.|+-+-+....+...+...
T Consensus 24 ipvfl~lt~~~~~~~r~~ia~~~~l~a~----~ill~f~~~G~~iL~~fgIsl~afrIaGGiiL~~ 85 (201)
T TIGR00427 24 IPIFISLTEYYTAAERNKIAKKANISSF----IILLIFLVFGDTILKLFGISIDAFRIAGGILLFT 85 (201)
T ss_pred HHHHHHHhCCCCHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHH
Confidence 3555555555666666666666554444 5555778889999999976666566655554433
No 62
>COG0798 ACR3 Arsenite efflux pump ACR3 and related permeases [Inorganic ion transport and metabolism]
Probab=23.44 E-value=6.4e+02 Score=23.86 Aligned_cols=26 Identities=15% Similarity=0.105 Sum_probs=20.1
Q ss_pred ccchhHHHHHHHHHHHHHHHHHHHHh
Q 013357 225 GLIGASLVLSLSWYIIVGAQFAYILM 250 (444)
Q Consensus 225 g~~g~~~a~~i~~~i~~~~~~~~~~~ 250 (444)
.-.|++++++++-++...++..+.+-
T Consensus 303 ~~s~aA~a~vigpLvEVpvml~lV~v 328 (342)
T COG0798 303 LTSGAALATVVGPLVEVPVMLGLVKV 328 (342)
T ss_pred ccccchhhhhccchhhHHHHHHHHHH
Confidence 37889999999988887777666543
No 63
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=23.20 E-value=2.9e+02 Score=19.85 Aligned_cols=34 Identities=18% Similarity=0.116 Sum_probs=25.2
Q ss_pred HHHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHH
Q 013357 111 TLCGQAYGAGRYEMLGVYMQRATFVLLATGVPVM 144 (444)
Q Consensus 111 ~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (444)
..+-..+.+||++++++.-+++..++.+..++..
T Consensus 42 ~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~~~g~ 75 (82)
T PF04505_consen 42 SKVRSRYAAGDYEGARRASRKAKKWSIIAIIIGI 75 (82)
T ss_pred hhhHHHHHCCCHHHHHHHHHHhHHHHHHHHHHHH
Confidence 5566677789999999999988887765444433
No 64
>PRK10995 inner membrane protein; Provisional
Probab=22.21 E-value=5.4e+02 Score=22.58 Aligned_cols=59 Identities=8% Similarity=0.064 Sum_probs=36.6
Q ss_pred HHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhccCcHHHHHHHHHHhH
Q 013357 333 VRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCP 395 (444)
Q Consensus 333 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~l~ 395 (444)
|..-..-.+.++++.++..++.....+ .+.++..++++.+.+.|.-+.+..+.+...+.
T Consensus 26 pif~~lt~~~~~~~r~~ia~~~~~~a~----~ill~f~~~G~~il~~fgIs~~a~rIaGGilL 84 (221)
T PRK10995 26 ALFLGLSGNMTPEERNRQALMASVYVF----AIMMVAFYAGQLVMSTFGISIPGLRIAGGLIV 84 (221)
T ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHH
Confidence 444444555666666666666554444 55557777888888888766555555554443
No 65
>KOG3832 consensus Predicted amino acid transporter [General function prediction only]
Probab=20.55 E-value=1.2e+02 Score=26.18 Aligned_cols=13 Identities=15% Similarity=-0.061 Sum_probs=7.5
Q ss_pred HHHHHHHHHHHHH
Q 013357 83 ELAAASLGNSGIQ 95 (444)
Q Consensus 83 ~~a~~~~a~~~~~ 95 (444)
+++.|+.+.+...
T Consensus 159 dlaiyaaavpfs~ 171 (319)
T KOG3832|consen 159 DLAIYAAAVPFSA 171 (319)
T ss_pred hhhhhhhcCchHh
Confidence 4566666665544
Done!